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Preface 
Enjoy the silence – unless you suffer from tinnitus. Our everyday lives are characterized by a 
constant exposure to sensory (over-) stimulation. Moments of quietness have become 
increasingly important for many of us in order to compensate for this overload, to calm down, 
to just let our senses get some rest. It is therefore not surprising that – if patients suffering 
from tinnitus are asked what their biggest problem about the phantom sound is – the answer 
often is that they miss the sound of silence and have problems to relax. Up to now, there is no 
cure for tinnitus and many patients have to try to live with the constant noise within their ears 
or head. From a scientific point of view, the way back to silence is still supposed to be a long 
one. The current thesis adds knowledge to tinnitus research in order to move one step closer 
towards a cure by investigating repetitive transcranial magnetic stimulation (rTMS) as a 
treatment option for chronic subjective tinnitus. 
 After some background information about tinnitus pathophysiology and the method of 
rTMS is given, three studies are presented which have the common aim to optimize rTMS 
treatment effects in tinnitus sufferers. In a concluding discussion, the results are put in a 
wider scientific context. As all three studies have already been published in peer-reviewed 
journals within the last four years, every study is presented as a stand-alone manuscript. The 
manuscripts were adapted so that the thesis as a whole meets the formatting requirements as 
described in the 6
th
 Edition of the Publication Manual of the American Psychological 
Association. All data are given as mean ± standard deviation unless otherwise specified. 
Decimal numbers were rounded to two decimal places with the exception of p-values smaller 
than .01 where three decimal places are reported. Tables and Figures were renumbered and 
placed after the section in which they were first mentioned (e.g. all tables mentioned in the 
methods of study 1 were placed after this section). Furthermore, the three separate reference 
sections were merged into one reference list at the end of the thesis. 
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Abstract 
Subjective tinnitus is a highly prevalent and for many patients very debilitating condition for 
which there is still no cure. As tinnitus has been shown to be associated with changes of 
neural activity in different areas of the cortex, repetitive transcranial magnetic stimulation 
(rTMS) has been used as a treatment tool in order to interfere with these changes. Up to now, 
treatment success is limited and strategies to enhance treatment effects are clearly needed. 
The three studies of this cumulative dissertation address the question how rTMS treatment of 
patients suffering from chronic subjective tinnitus can be optimized. Study 1 tested whether 
treatment response was associated with grey matter (GM) changes and whether pre-treatment 
GM volume might be a potential predictor for treatment success. Although transient GM 
changes in the insulae and the bilateral inferior frontal cortex were observed, these changes 
were not correlated to treatment outcome. It was shown, however, that GM volume in the 
frontal cortex and the lingual gyrus might be possible predictors for treatment response. 
While traditionally, rTMS targeted the auditory cortex of tinnitus patients, study 2 and study 
3 examined a new protocol which stimulated three sites successively in order to better 
interfere with cortical networks involved in tinnitus pathophysiology: the left dorsolateral 
prefrontal cortex and the left and right temporoparietal cortices. Study 2 was a pilot study 
which tested the new protocol in a one-arm open label study and compared the results with a 
historical control group of patients receiving traditional single-site stimulation. The results 
suggested that the triple-site protocol might show better long-term effects. As a consequence, 
the new protocol was explored in more detail in study 3 in order to replicate the result in a 
randomized controlled parallel group trial. In this study, the superiority of the multisite 
protocol was only seen on a descriptive but not on a statistical significant level. In a 
concluding discussion, the methods used in this work and future approaches for the 
enhancement of rTMS treatment effects are discussed. 
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Zusammenfassung 
Subjektiver Tinnitus ist ein weit verbreitetes und für viele Betroffene sehr beeinträchtigendes 
Symptom, für das bis dato keine Heilungsmethode existiert. Da gezeigt wurde, dass Tinnitus 
mit Veränderungen der neuronalen Aktivität in verschiedenen kortikalen Arealen einhergeht, 
wird seit einiger Zeit die repetitive transkranielle Magnetstimulation (rTMS) als 
Behandlungsmöglichkeit erforscht, die an genau diesen neuronalen Veränderungen 
anzusetzen versucht. Der Erfolg dieser Behandlungsmethode ist bislang begrenzt. Deshalb 
beschäftigen sich die drei Studien der vorliegenden kumulativen Dissertation mit der Frage, 
wie die rTMS Behandlung bei chronischem Tinnitus optimiert werden kann. In Studie 1 
wurde untersucht, ob der Behandlungserfolg mit Veränderungen in der grauen Substanz 
einhergeht und ob das Volumen der grauen Substanz vor Behandlungsbeginn möglicherweise 
ein potenzieller Prädiktor für den Behandlungserfolg darstellt. Auch wenn vorübergehende 
Veränderungen der grauen Substanz bilateral in der Insula und dem inferioren frontalen 
Kortex gefunden wurden, so korrelierten diese Veränderungen jedoch nicht mit dem 
Behandlungsergebnis. Es zeigte sich aber, dass das Volumen der grauen Substanz im 
frontalen Kortex und dem Gyrus lingualis potenzielle Prädiktoren für den Behandlungserfolg 
darstellen könnten. 
Während ursprünglich der auditorische Kortex von Tinnituspatienten als Zielort für die rTMS 
diente, wurde in Studie 2 und Studie 3 ein neuartiges Stimulationsprotokoll untersucht. 
Dieses Protokoll sieht eine sukzessive Stimulation von drei kortikalen Arealen vor und 
verfolgt dabei das Ziel, die an der Pathophysiologie des Tinnitus beteiligten neuronalen 
Netzwerke besser beeinflussen zu können. Stimuliert wurden der linke dorsolaterale 
präfrontale Kortex sowie der linke und rechte temporoparietale Kortex. Studie 2 war eine 
Pilotstudie in welcher dieses neue Protokoll in einem einarmigen, nicht-verblindeten 
Studiendesign untersucht wurde und dann mit einer Kontrollgruppe aus einer früheren Studie 
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verglichen wurden. Die Patienten der Kontrollgruppe hatten die traditionelle linkstemporale 
Stimulation erhalten. Die Ergebnisse legten nahe, dass das neue Stimulationsprotokoll 
bessere Langzeiteffekte erzielt als das traditionelle Protokoll. Studie 3 wurde schließlich 
konzipiert, um dieses vielversprechende Ergebnis in einer randomisierten, kontrollierten 
Studie mit Parallelgruppen zu replizieren. In dieser Studie war das neue Protokoll zwar auf 
deskriptiver Ebene überlegen, dieser Unterschied war jedoch nicht statistisch signifikant. 
In einer zusammenfassenden Diskussion werden die Methoden, die in dieser Arbeit 
Verwendung fanden sowie zukünftige Möglichkeiten zur Verbesserung der rTMS-
Behandlung diskutiert.
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Introduction 
Tinnitus 
 Definition. 
 Tinnitus is the perception of a sound or noise in the absence of an external acoustic 
stimulus. If there is a sound source within the body e.g. altered blood flow or muscle 
movement (Langguth, Kreuzer, Kleinjung, & De Ridder, 2013), the sound can also be heard 
by the examiner and is therefore called objective. In the much more prevalent subjective 
tinnitus, the sound is only heard by the patient and no inner-body source for this percept can 
be identified. In many cases, tinnitus is experienced acutely for only a few minutes or hours 
and the person recovers spontaneously. The phantom sound is considered chronic if it is 
perceived for at least three to six months (Hall et al., 2011; Landgrebe et al., 2008). Acute 
tinnitus is a very common symptom which about 25% of the adults in the US have 
experienced at least once (Shargorodsky, Curhan, & Farwell, 2010). About 10-15% of the 
population experience tinnitus in its chronic form (Axelsson & Ringdahl, 1989; Hoffman, H. 
J. & Reed, 2004). In the current thesis, only patients with chronic subjective tinnitus were 
treated. Therefore, the term tinnitus always means chronic subjective tinnitus unless 
otherwise specified. 
 
 Pathophysiology I: from peripheral damage to auditory cortex. 
 While traditionally, tinnitus was thought to be a pure otological symptom, the current 
state of research clearly suggests that tinnitus has many possible causes involving both 
peripheral and central sensory pathways and that in many patients there is not a single trigger 
but rather multiple influences which may eventually result in a phantom sound (Langguth et 
al., 2013). Still, tinnitus is supposed to be usually initiated by peripheral mechanisms such as 
cochlear damage. This assumption is backed by etiological studies which clearly indicate that 
INTRODUCTION 
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hearing loss is a dominant risk factor for tinnitus (Axelsson & Ringdahl, 1989; Hoffman, H. 
J. & Reed, 2004). Furthermore, even in patients with normal audiograms, some form of 
auditory deafferentation might exist (Schaette & McAlpine, 2011; Weisz, Hartmann, 
Dohrmann, Schlee, & Norena, 2006). This peripheral damage causes altered auditory input to 
the central auditory pathway where plastic changes are supposed to occur in order to 
compensate for this altered input (Eggermont & Roberts, 2004; Roberts, L. E. et al., 2010). 
The exact mechanisms by which the auditory pathway might (mal-)adapt to hearing loss and 
thus create a phantom sound are not yet completely understood. There are different models 
which try to explain this process such as the thalamocortical-dysrhythmia model which 
suggests that deafferentation due to hearing loss leads to a reduced lateral inhibition and 
therefore to increased firing rates in surrounding areas of the dorsal and ventral cochlear 
nucleus and the inferior colliculus. This is supposed to cause a reorganization of the tonotopic 
maps and increased neural synchrony in those auditory structures. As a consequence a 
phantom sound occurs (De Ridder, Vanneste, Langguth, & Llinas, 2015; Roberts, L. E. et al., 
2010). 
The influence of deafferentation is not limited to peripheral or subcortical structures 
but also affects the auditory pathway at level of the auditory cortex. Studies using different 
methods to measure central neural activity in tinnitus patients report some sort of 
hyperactivity in the temporal cortex. For example, studies employing electroencephalography 
(EEG) or magnetoencephalography (MEG) have shown an increase of gamma activity in the 
auditory cortex (Weisz, Dohrmann, & Elbert, 2007) which is correlated with tinnitus 
loudness and which parallels findings of gamma band activity in physiological processing of 
auditory signals (van der Loo et al., 2009; Weisz et al., 2007). This tinnitus-related increased 
gamma band activity might be the consequence of reduced inhibitory alpha band activity 
which has also been observed over temporal areas of tinnitus patients (Schlee et al., 2014; 
INTRODUCTION 
| 15  
 
Weisz, Moratti, Meinzer, Dohrmann, & Elbert, 2005). Also studies using neuroimaging 
methods clearly indicate that the activity in the auditory cortex of tinnitus patients is altered. 
For example, enhanced activity of the left auditory cortex has been shown (Arnold, 
Bartenstein, Oestreicher, Romer, & Schwaiger, 1996) as well as elevated sound evoked 
activity in the primary auditory cortex of tinnitus patients (Gu, Halpin, Nam, Levine, & 
Melcher, 2010). All in all, the involvement of the auditory cortex in the generation of tinnitus 
seems now to be unambiguous. However, activity in the auditory cortex alone may well be 
insufficient for the generation of a conscious auditory percept. 
 
 Excursus: conscious auditory perception in healthy humans. 
 Studies in patients suffering from unresponsive wakefulness syndrome i.e. patients 
who awaken from coma but remain unresponsive (Laureys et al., 2010) have provided 
important information about healthy sensory processing in general and auditory processing in 
particular. It has been shown that if a an auditory stimulus was presented to those patients in 
comparison to controls, the auditory cortices were activated in both groups whereas patients 
showed a lack of activation of the temporoparietal junction and also a lack of functional 
connectivity between the auditory cortex and higher-order areas like parts of the parietal and 
cingulate cortex (Laureys et al., 2000). This indicates that besides the activation of the 
sensory pathway itself, activity of a fronto-parieto-cingular network is additionally required 
for a conscious auditory percept. This network is assumed to modulate the activity in sensory 
cortices via top-down amplification or inhibition (Dehaene & Changeux, 2004). 
 
 Pathophysiology II: from auditory cortex to a conscious, distressing percept. 
 Although there is no objective sound source for tinnitus, it still is a conscious auditory 
percept. It can therefore be assumed that – just as for any other auditory percept – the 
INTRODUCTION 
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involvement of higher-order areas should play a role in tinnitus as well. Indeed, 
neuroimaging studies suggest that alterations of activity in the central nervous system of 
tinnitus patients exceed the auditory cortex and are also present in distant, non-auditory 
cortical regions such as frontal and parietal areas (Adjamian, Sereda, & Hall, 2009; Lanting, 
de Kleine, & van Dijk, 2009). There are some preliminary results which back the hypothesis 
that the simultaneous activity of the auditory cortex and a fronto-parieto-cingular network are 
crucial for a conscious tinnitus percept to appear (De Ridder, Elgoyhen, Romo, & Langguth, 
2011). For instance, Schlee, Hartmann, Langguth, and Weisz (2009) observed an increased 
long-range gamma coupling between temporal, frontal, parietal and cingulate cortices in 
resting state MEG of tinnitus patients as compared to healthy controls. Furthermore, it was 
found that “the more the activity in the temporal cortices was driven by other brain regions 
the stronger the subjective distress” (Schlee, Mueller, et al., 2009, p.6) stressing the top-down 
influence of non-auditory brain regions. Besides this fronto-parieto-cingular network, another 
subnetwork is supposed to play a role in tinnitus: an unspecific “distress network” which is 
thought to represent the affective component of the phantom sound and which is most likely 
composed of the anterior cingulate cortex, the insula, amygdala and parahippocampus (van 
der Loo, Congedo, Vanneste, Van De Heyning, & De Ridder, 2011; Vanneste et al., 2010). 
This concept of different neural subnetworks, which are considered to represent separable 
characteristics of the tinnitus percept (De Ridder et al., 2014), are precious input for 
researchers trying to find new treatment options and are therefore of particular importance for 
the current work. 
 
 Treatment of tinnitus. 
 To date, there is no cure for chronic subjective tinnitus and often there is also no clear 
indication for a specific, causally oriented treatment option. Possible treatment approaches 
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include psychological interventions such as counselling or cognitive behavioural therapy 
(CBT). There is evidence that CBT is able to improve tinnitus patients’ quality of life but is 
not able to reduce tinnitus intensity (Cima et al., 2012; Martinez-Devesa, Perera, Theodoulou, 
& Waddell, 2010). In addition, different pharmacological treatments and auditory stimulation 
techniques are being examined like hearing aids, cochlea implants or sound therapy (for an 
overview, see Fernandez, Shin, Scherer, & Murdin, 2015; Langguth et al., 2013). Finally, 
brain stimulation techniques such as transcranial direct current stimulation (Song, Vanneste, 
Van de Heyning, & De Ridder, 2012), transcranial random noise stimulation (Vanneste, 
Fregni, & De Ridder, 2013) or repetitive transcranial magnetic stimulation (rTMS) have also 
been introduced as possible treatment options (Langguth, de Ridder, et al., 2008). 
 
Repetitive transcranial magnetic stimulation 
 Explanation of the method. 
 Transcranial magnetic stimulation is a non-invasive brain stimulation technique, 
which uses electromagnetic induction to induce electric currents in the brain. To this end, a 
coil of wire is placed above the scalp while a current pulse is produced within the coil 
resulting in a magnetic field. This magnetic field induces an electrical field able to depolarize 
axons, which lie perpendicular to the induced current (Hallett, 2000; Siebner, Hartwigsen, 
Kassuba, & Rothwell, 2009). The effects of rTMS are state-dependent which means that 
TMS effects differ according to the initial activation state of the stimulated neurons (Dayan, 
Censor, Buch, Sandrini, & Cohen, 2013). Probably, neurons are most prone to becoming 
depolarized by a TMS pulse if their membrane potential is just below the threshold (Siebner 
et al., 2009). 
 The stimulation depth of TMS is dependent on the type of coil and reaches one to six 
centimetres. The strength of the induced electrical field decreases with increasing stimulation 
INTRODUCTION 
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depth. Therefore, TMS is only able to depolarize superficial cortical neurons (Siebner & 
Ziemann, 2007). However, due to axonal projections and network connections within the 
brain, TMS also exerts indirect influence on activity in cortical areas distant from the 
stimulation site. Again, these effects are state-dependent with TMS exerting stronger impact 
on cortico-cortical connections which are in an activated state (Siebner et al., 2009). 
 
 TMS and the human brain: 30 years in a nutshell. 
 In 1985, Anthony Barker was the first to use TMS in order to stimulate the motor 
cortex of humans (Barker, Jalinous, & Freeston, 1985). He found that if the coil is placed 
over the motor cortex, single TMS pulses can induce neural activation in the underlying 
cortical area resulting in movements of the respective contralateral limb. Thereafter, TMS 
was established as a diagnostic tool to measure motor evoked potentials (Kobayashi & 
Pascual-Leone, 2003; Rossini et al., 1994) and other parameters of motor cortex excitability 
(Siebner & Ziemann, 2007). Since its introduction, TMS has been used to investigate causal 
links between brain structures and inter-regional functional interactions (Dayan et al., 2013). 
After it had been shown that the repeated application of TMS pulses (rTMS) resulted 
in changes of the cortical excitability of the motor cortex, which outlasted the stimulation 
period (Fitzgerald, Fountain, & Daskalakis, 2006; Rossini et al., 2015), it became possible to 
use rTMS as a therapeutic tool which allowed the investigator to actively modulate cortical 
excitability. The precise direction of the rTMS effect is thought to depend on the frequency of 
the applied TMS pulses. While low-frequency (1 Hz) rTMS was shown to inhibit the cortical 
excitability of the motor cortex, high-frequency rTMS increased it (Dayan et al., 2013). The 
specific biophysical mechanisms underlying this modulating effect are not completely 
understood but it is supposed that rTMS initiates long-term potentiation or long-term 
depression-like effects (Dayan et al., 2013). 
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 rTMS for the treatment of chronic tinnitus. 
 As a painless, safe technique to manipulate cortical activity with only little adverse 
effects (Rossi, Hallett, Rossini, & Pascual-Leone, 2009), rTMS has been explored as a 
treatment option for neurological and psychiatric disorders associated with changes of 
cortical excitability (Lefaucheur et al., 2014). After it had been shown that low-frequency 
rTMS of the left temporal cortex could reduce auditory hallucinations in patients suffering 
from schizophrenia (Hoffman, R. E. et al., 2000) it was hypothesized that this might also be 
useful in the treatment of other phantom percepts such as subjective tinnitus. The 
hyperactivity observed in the auditory cortex of tinnitus patients posed a promising target for 
the modulatory effects of low-frequency rTMS. Indeed, some studies reported a transient 
reduction of tinnitus intensity after the auditory cortex of tinnitus patients was targeted with 
about 200 pulses of 1 Hz TMS (Folmer, Carroll, Rahim, Shi, & Hal Martin, 2006; Lefaucheur 
et al., 2014) and this effect was shown to be dose-dependent with more TMS pulses resulting 
in longer lasting effects (Plewnia et al., 2007). Since 2003 (Langguth et al., 2003) many 
studies have investigated the effect of repeated rTMS sessions for the treatment of tinnitus. 
Usually, five to ten daily rTMS sessions have been used with each session consisting of about 
1000 pulses of low-frequency rTMS of the left temporal or left temporoparietal cortex. The 
results are mixed with some sham-controlled studies reporting beneficial effects while others 
do not. Three recently published reviews differ in their conclusions drawn: While Meng et al. 
(2011) state that there is only limited support for the use of low-frequency rTMS for the 
treatment of tinnitus, Soleimani et al. (2015) report medium to large effect sizes especially at 
follow-up assessments and Lefaucheur et al. (2014) conclude that there is a possible 
therapeutic efficacy. In any case, treatment effects are burdened by high inter-individual 
variability, the reported effects are transient and complete disappearance of the phantom 
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sound is rare (Lefaucheur et al., 2014). Therefore, efforts to enhance treatment success are 
clearly indicated. 
To this end, different strategies have been proposed and tried such as the combination 
of rTMS with pharmacological interventions (Kleinjung et al., 2009, 2011), the investigation 
of different firing modes such as theta burst stimulation (Plewnia et al., 2012; Schecklmann et 
al., 2016) or the identification of clinical and demographical parameters to identify potential 
treatment responders (Frank, G. et al., 2010; Lehner et al., 2012). All those efforts have not 
yet resulted in significant improvements of rTMS treatment. Another approach to optimize 
treatment effects is to modify the cortical area which is stimulated. While rTMS has 
traditionally been applied to the left auditory cortex, the new insights in tinnitus 
pathophysiology indicate that stimulation of the auditory cortex alone might not be sufficient 
to achieve a long lasting improvement of tinnitus severity. If several separable networks 
including both auditory and non-auditory brain structures are involved in the generation of 
chronic tinnitus (De Ridder et al., 2011), targeting also non-auditory cortical areas could be a 
promising approach to optimize treatment effects. 
INTRODUCTION 
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Scope of the present thesis 
 This cumulative dissertation is composed of three studies all of which have a common 
aim: They intend to investigate how the effects of rTMS treatment of tinnitus can be 
enhanced. In all three studies, patients suffering from chronic subjective tinnitus were treated 
with ten daily sessions of rTMS. 
Study 1 focused on the neural mechanisms by which the well-investigated standard 
stimulation protocol of low-frequency rTMS of the auditory cortex exerts its effects. If we 
understand why some patients benefit from rTMS treatment while others do not, this might 
enable us to better tailor the treatment protocols to the individual patient’s needs. Therefore, 
study 1 analyzed whether structural changes in the cortical grey matter (GM) of tinnitus 
patients’ brains might be able to explain the high inter-individual variability of treatment 
effects. More precisely, the study intended to answer the questions whether (a) there are any 
GM changes detectable after low-frequency rTMS of the auditory cortex, (b) these changes 
are associated with treatment success, and (c) the GM volume before the first treatment 
session might be useful as a predictor for treatment outcome. Accordingly, high-resolution 
images of the patients’ brains were acquired before and after ten daily rTMS treatment 
sessions. Those images were analyzed by means of voxel based morphometry (VBM) and 
correlated with clinical measures of treatment outcome. 
In Study 2 and 3 an optimization of treatment protocol was developed which takes 
the already existing knowledge about tinnitus pathophysiology into account. Assuming that 
both auditory and non-auditory cortical networks are involved in tinnitus generation and 
chronification, the protocol targets three central hubs of these networks. Study 2 is a pilot 
study in which this triple-site protocol was examined for the very first time in a one-arm open 
label study in order to find out whether triple-site stimuluation was safe and applicable in 
daily clinical routine and whether it had potential to augment treatment effects. To this end, 
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the protocol was compared to a historical control group which had been treated with standard 
low-frequency rTMS of the left temporal cortex. In order to replicate the results of this pilot 
study, study 3 was conducted in which the triple-site protocol was compared to the standard 
stimulation protocol in a randomized controlled, parallel-group clinical trial. 
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Abstract 
Repetitive transcranial magnetic stimulation (rTMS) of the temporal cortex has been used to 
treat patients with subjective tinnitus. While rTMS is known to induce morphological 
changes in healthy subjects, no study has investigated yet whether rTMS treatment induces 
GM changes in tinnitus patients as well, whether these changes are correlated with treatment 
success and whether GM at baseline is a useful predictor for treatment outcome. Therefore, 
we examined magnetic resonance images of 77 tinnitus patients who were treated with rTMS 
of the left temporal cortex (10 days, 2000 stimuli/day, 1 Hz). At baseline and after the last 
treatment session high-resolution structural images of the brain were acquired and tinnitus 
severity was assessed. For a subgroup of 41 patients, additional brain scans were done after a 
follow-up period of 90 days. GM changes were analysed by means of VBM. Transient GM 
decreases were detectable in several brain regions, especially in the insula and the inferior 
frontal cortex. These changes were not related to treatment outcome though. Baseline images 
correlated with change in tinnitus severity in the frontal cortex and the lingual gyrus, 
suggesting that GM at baseline might hold potential as a possible predictor for treatment 
outcome. 
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Introduction 
 Subjective tinnitus is the phantom perception of a sound in the absence of a 
corresponding objective sound source. With about 25% of adults in the US having 
experienced a ringing in the ears at least once (Shargorodsky et al., 2010), transient tinnitus is 
a common phenomenon. About 10-15% of the world population experience tinnitus in its 
chronic form (Axelsson & Ringdahl, 1989). While the majority of those 10-15% gets used to 
their tinnitus and is able to lead a normal life, in 1-3% of the general population tinnitus is 
experienced as extremely bothersome and debilitating. It can severely affect patients’ 
everyday lives and is often accompanied by psychiatric comorbidities such as depressive 
syndromes or sleep disturbances (Axelsson & Ringdahl, 1989; Langguth, 2011). In order to 
improve existing treatment options and also to generate new treatment strategies for 
subjective tinnitus, it is mandatory to broaden knowledge on the neural mechanisms 
underlying the tinnitus percept. 
 More than 15 years ago it has been suggested (Jastreboff, 1990; Moller, 1997) and 
demonstrated (Arnold et al., 1996) that tinnitus is related to alterations in the central nervous 
system. Furthermore, recent functional neuroimaging studies suggest (Adjamian et al., 2009; 
Lanting et al., 2009; Song, De Ridder, Van de Heyning, & Vanneste, 2012; Vanneste & De 
Ridder, 2012) that, apart from the auditory cortex, widespread neural networks involving 
many different brain areas seem to be involved in the generation and maintenance of the 
phantom sounds as well as in the distress accompanied by the tinnitus percept (De Ridder et 
al., 2011; Langguth et al., 2013). In addition to functional alterations within the brain, tinnitus 
has also been shown to be related to structural brain changes (Schecklmann et al., 2013). 
Studies using high-resolution magnetic resonance imaging (MRI) to compare the GM volume 
and cortical thickness of tinnitus patients with healthy control subjects have revealed 
alterations in the auditory cortex (Aldhafeeri, Mackenzie, Kay, Alghamdi, & Sluming, 2012; 
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Boyen, Langers, de Kleine, & van Dijk, 2013; Schneider et al., 2009) and in subcortical parts 
of the central auditory pathway like the thalamus (Muhlau et al., 2006) and the right inferior 
colliculus (Landgrebe et al., 2009). Furthermore, alterations in GM volume and cortical 
thickness were also found in non-auditory brain locations (Aldhafeeri et al., 2012; Diesch, 
Schummer, Kramer, & Rupp, 2012; Landgrebe et al., 2009; Leaver et al., 2011, 2012; 
Muhlau et al., 2006). 
The knowledge that subjective tinnitus is associated with neural alterations suggests 
the therapeutic use of brain stimulation techniques such as rTMS. The early finding that the 
auditory cortex is overly active in tinnitus patients (Arnold et al., 1996) led to the idea to use 
low-frequency rTMS to modify the cortical hyperactivity in patients with phantom sounds 
(Eichhammer, Langguth, Marienhagen, Kleinjung, & Hajak, 2003). Ever since then low-
frequency rTMS has been investigated in an increasing number of studies (for a review, see 
Langguth & De Ridder, 2013) showing that rTMS is effective with high inter-individual 
variability. However, it is still difficult to identify predictors for treatment success (Lehner et 
al., 2012). The idea to use and improve rTMS as a treatment for tinnitus is further pursued 
though. To gain deeper insight into the mechanisms of rTMS treatment – and consequently to 
facilitate improvement of the therapeutic approach -- the complementary use of both 
longitudinal neuroimaging and clinical assessment to measure rTMS effects in tinnitus 
patients is an important next step in tinnitus research (Langguth et al., 2012). The number of 
studies addressing this issue is limited so far. Some studies investigated the effect of low-
frequency rTMS treatment on auditory evoked potentials and auditory steady state responses 
using EEG and MEG (Lefaucheur et al., 2012; Lorenz, Muller, Schlee, Langguth, & Weisz, 
2010; Yang et al., 2013). Two studies using single-photon emission computed tomography 
and functional magnetic resonance imaging (fMRI) found changes of neural activity in the 
temporal lobe, the right cingulate gyrus and the uncus (Lefaucheur et al., 2012; Marcondes et 
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al., 2010). While those studies have provided first insight in the functional alterations that are 
associated with low-frequency rTMS of the auditory cortex, there is no study which adds 
knowledge about structural alterations induced by rTMS treatment in tinnitus patients. Until 
now, only one study examined the effect of low-frequency rTMS over the left auditory cortex 
in healthy subjects using VBM (May et al., 2007). The results suggest that five days of rTMS 
treatment lead to GM changes in the auditory cortex and the thalamus. 
Based on all those results the current study was conducted with the following three 
research questions in mind: (1) Is there a change in GM detectable in tinnitus patients after 10 
sessions of rTMS treatment and after a follow-up period of 90 days? (2) Is there a 
relationship between the clinical outcome and the GM changes? (3) Can structural imaging 
be used as a predictor for outcome? To answer these questions we evaluated MRI scans of 
patients suffering from subjective tinnitus which were done routinely before and after low-
frequency rTMS of the temporal cortex. 
 
Materials and Methods 
 Subjects. 
 Data from 77 patients (59 male, 18 female) with chronic tinnitus were included in the 
analyses. Patients with cardiac pacemakers, history of seizures or any severe somatic, 
neurologic or psychiatric disorder were excluded. The decision whether a patient was 
suffering from any severe somatic, neurologic or psychiatric disorder was made by the 
physician, who decided about study inclusion based on the global clinical impression. One 
criterion for a severe somatic, neurologic or psychiatric disorder was the need for an 
immediate therapeutic action for the treatment of this disorder. Another criterion was current 
hospitalisation because of such disorder. 
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All patients were treated with rTMS and underwent MRI scanning before (baseline) 
and after (day 12) 10 sessions of rTMS treatment. In a subgroup of 41 patients an additional 
measurement was done after a follow-up period of three months (day 90). The total sample of 
77 patients was therefore divided into two independent subgroups of one sample with two 
scans (n = 36) and one sample with three scans (n = 41). Demographical and clinical 
characteristics for both subgroups are shown in Table 1. Audiological data and a measure of 
hyperacusis were not available for all patients and could therefore not be included in the 
further analyses. Standardized pure tone audiometry data was available for 57 patients and 
revealed a mean hearing loss of 20.38 ± 12.14 decibel hearing level (dB HL, average of all 
thresholds measured bilaterally ranging from 125 Hz to 8 kHz). As a screening measure of 
hyperacusis patients were asked whether “sounds cause pain or physical discomfort” 
(Schecklmann, Landgrebe, & Langguth, 2014). Of the 61 patients who answered this 
question 35 said yes and are therefore supposed to suffer from hyperacusis. Independent 
samples t-tests and Chi
2
-tests revealed no significant difference between the two independent 
subgroups concerning all variables reported in Table 1. 
 
 Repetitive transcranial magnetic stimulation. 
 rTMS treatment consisted of 10 treatment sessions on 10 consecutive working days. 
Patients were either treated in the context of several clinical trials (Kleinjung et al., 2008, 
2009; Langguth et al., 2014) or rTMS was done as compassionate use treatment between 
2006 and 2009. Patients were stimulated over the left temporal cortex (1Hz, 2000 stimuli/day, 
110% resting motor threshold, RMT) which was either localized by using a standard 
procedure targeting the primary auditory cortex based on the 10-20-system (Jasper, 1958; 
Langguth et al., 2006) or by using neuronavigation based on individual MRI or PET (positron 
emission tomography) images. In the latter cases, the area of increased activation within the 
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primary auditory cortex was used as target area. Even if these two methods may have resulted 
in slightly different targets, the spatial difference is smaller than the spatial accuracy of rTMS 
treatment with the used figure-of-eight coil. For rTMS treatment, a Medtronic system with a 
figure-of-eight coil was used (90 mm outer diameter; Medtronic, Minneapolis, MN). The coil 
was held with a mechanical arm and placed over the left temporal cortex with the handle of 
the coil pointing upwards. During treatment, the patients were seated in a comfortable 
treatment chair. The resting motor threshold (RMT) was measured once before the first 
treatment session and was defined as the minimal intensity at which at least four out of eight 
magnetically evoked potentials were ≥ 50 µV in amplitude in the right abductor digiti minimi 
muscle (Rossini et al., 1994). All patients were treated at the Tinnitus Centre at the University 
of Regensburg, Germany, and provided written informed consent. The treatment protocol has 
been approved by the local ethics committee. 
 
 Clinical assessment. 
 For the assessment of demographical and clinical characteristics, the Tinnitus Sample 
Case History Questionnaire was used (Langguth et al., 2007). Tinnitus severity was assessed 
using the German version of the Tinnitus Questionnaire (TQ; Goebel & Hiller, 1994; Hallam, 
Jakes, & Hinchcliffe, 1988) and a numeric rating scale, which measured how loud the tinnitus 
was perceived (“How strong or loud is your tinnitus at present?”). This scale was rated from 
0 (not loud at all) to 10 (extremely strong or loud). These measures were assessed before the 
first treatment session (baseline), after the last treatment session (day 12) and – for the 
subgroup of 41 patients with three images -- after the follow-up period of three months (day 
90). 
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 MRI. 
 A Siemens Sonata 1.5-Tesla whole body scanner (Siemens AG, Erlangen) with a 
standard 8-channel birdcage head coil was used to collect the anatomical images. For each 
subject and each time point, a high-resolution T1-weighted image was acquired using a 
magnetization-prepared-rapid-acquisition-gradient-echo (MP-RAGE) sequence (repetition 
time 1880 ms; echo time 3.42 ms; flip angle 15°; matrix size 256x256; number of slices 176; 
voxel size 1x1x1mm³). 
 
 Data processing and statistical analysis. 
 For statistical analyses of the clinical data, PASW statistics 18 (SPSS Inc., Chicago, 
IL) was used. To test for changes in tinnitus severity an analysis of variance (ANOVA) with 
the within-subjects factor time (baseline, day 12, day 90) was calculated for both the TQ and 
the loudness scale. In case of significant results, post-hoc paired t-tests were done. For the 
group of 36 patients with only two assessments, paired t-tests were used to compare the TQ 
and loudness on baseline and day 12. All statistical tests were two-tailed. The level of 
significance was set at .05. 
Processing and statistical analysis of the anatomical data were performed with the 
SPM8 software package (Statistical Parametric Mapping, Wellcome Trust Centre for 
Neuroimaging, http://www.fil.ion.ucl.ac.uk/spm). All anatomical images were visually 
examined for the presence of morphological abnormalities or artefacts. Preprocessing of the 
anatomical data was done using the standard procedure of the VBM toolbox (VBM8 Version 
435, Structural Brain Mapping Group, http://dbm.neuro.uni-jena.de/vbm) for longitudinal 
data and involved intra-subject realignment, bias correction, segmentation and normalization 
to the Montreal Neurological Institute (MNI) space. The default options of the standard 
procedure were not changed. As modulation is not necessary for longitudinal data, 
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unmodulated images were used. Afterwards, a quality check was done using VBM8 before 
smoothing data with a Gaussian kernel of 8mm full-width at half maximum. Only GM 
images were used for further analyses. For the statistical analyses all voxels with a GM value 
below 0.1 were excluded to avoid edge effects around the border between grey and white 
matter. All analyses were done for the overall group of 77 patients (baseline and day 12 
scans) as this group provided the highest statistical power. Additionally, all analyses were 
also done for the independent subgroups with two (n = 36) and three (n = 41) MRI scans. The 
following whole-brain analyses were performed: 
(1) GM images acquired at every time point were compared by estimating a flexible 
factorial model in SPM8 with the factors subject and time (baseline, day 12, day 90). 
(2) To test for correlations between the GM changes over time and changes in the 
clinical outcome parameters, difference images were calculated using the image calculator 
implemented in SPM8 (day 12 – baseline, day 90 – baseline) and correlated with the 
corresponding difference in the TQ and loudness scores. 
(3) To find out whether GM images might be useful as a predictor for clinical 
outcome, baseline images were correlated with the difference in the TQ score (day 12 – 
baseline). Please see Table 2 for an overview of all analyses done. 
For all analyses, the significance threshold was set to p < .001 (uncorrected) at voxel 
level and p < .05 (family-wise error, FWE, corrected) at cluster level. Due to the non-
isotropic smoothness of VBM data, correction for non-stationarity was applied. Anatomical 
Automatic Labeling (Tzourio-Mazoyer et al., 2002) and the SPM Anatomy Toolbox 
(Eickhoff et al., 2005) were used for anatomic labelling of significant clusters. 
 
  
 
Table 1 
Demographical data and clinical characteristics for both independent subgroups 
 
VBM data at baseline, day 12 
and day 90 
(n  = 41) 
VBM data at baseline 
and day 12 
(n = 36) 
group comparison 
 
p-value 
gender 32 m (78 %); 9 f (22 %) 27 m (75 %); 9 f (25 %) χ2(1,77) = 0.10 .75 
age (years) 50.72  ± 13.37 50.79 ± 13.28 t(75) = -0.02 .98 
tinnitus laterality 10 % right, 15 % left 
75 % bilateral 
14 % right, 14 % left 
72 % bilateral 
χ2(2,77) = 0.32 .85 
tinnitus duration (years) 8.97 ± 8.36 7.57 ± 6.74 t(75) = 0.80 .43 
TQ (baseline) 36.61 ± 17.78 39.56 ± 18.21 t(75) = -0.72 .48 
loudness (baseline) 6.32 ± 2.04 6.00 ± 2.11 t(75) = 0.67 .44 
mean hearing threshold [dB HL] 21.67 ± 11.49 (n = 29) 19.06 ± 12.85 (n = 28) t(55) = 0.81 .42 
hyperacusis 51% (n = 39) 68% (n = 22) χ2(2,61) = 2.31 .32 
Note. TQ: Tinnitus Questionnaire; loudness: How STRONG or LOUD is tinnitus at present (0 Not at all, 10 Extremely strong or loud); mean 
hearing threshold: average of all thresholds measured bilaterally ranging from 125 Hz to 8 kHz).
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Table 2 
Overview over all VBM analyses 
 Statistics 
Research question 
n = 41 
(3 scans) 
n = 36 
(2 scans) 
N = 77 
(2 scans) 
GM changes after 
rTMS? 
Flexible factorial models with factors subject + time 
time points: 
baseline, day 12, 
day 90 
time points: 
baseline, day 12 
 
time points: 
baseline, day 12 
 
Correlation between 
GM changes and 
clinical outcome 
parameters? 
Correlation of difference in the TQ and loudness rating with 
difference images 
time difference: 
day 12 – baseline 
day 90 – baseline 
 
time difference: 
day 12 - baseline 
time difference: 
day 12 - baseline 
GM as predictor for 
treatment response? 
Correlation of difference in the TQ with baseline images 
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Results 
 Clinical outcome. 
 The paired t-tests comparing the TQ and the loudness differences between baseline 
and day 12 in the overall group of 77 patients revealed a significant decrease in the TQ score 
(t(76) = 2.47, p = .016) and a marginally significant decrease in the loudness rating 
(t(76) = 1.75, p = .085). The paired t-tests comparing the TQ and the loudness differences 
between baseline and day 12 in the subgroup with only two scans (n = 36) revealed a 
significant decrease in the TQ score (t(35) = 2.29, p = .028) and no significant change in the 
loudness rating (t(35) = -0.10, p = .92). The ANOVA comparing the TQ scores of the 
subgroup with three scans (n = 41) revealed no significant effect of time (F(1.70, 
67.82) = 1.74, p = .19). The ANOVA comparing the loudness scores of all three time points 
suggested a significant difference between at least two time points (F(2, 80) = 3.52, p = .034). 
Post-hoc paired t-tests revealed a significant decrease from baseline to day 12 (t(40) = 2.53, 
p = .015) and a marginally significant decrease from baseline to day 90 (t(40) = 2.01, 
p = .052). There was no significant change from day 12 to day 90 (t(40) = -0.37, p = .71). See 
Figure 1 for a line chart showing the development of the TQ and loudness scores over time. 
 
 VBM. 
 (1) The flexible factorial models revealed significant GM concentration decreases 
from baseline to day 12 in the left and right insula as well as in the left and right inferior 
frontal gyrus (please see Figure 2 and Table 3 for MNI coordinates and statistical details). 
These GM changes were visible in both the n = 41 and the overall patient sample with 77 
patients. It was not detected in the n = 36 sample though. If data of this group was analysed 
with a more relaxed statistical threshold (p < .05 (uncorrected) at voxel level and p < .05 
FWE corrected at cluster level), GM decreases were found in the right inferior frontal gyrus 
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(x = 40, y = 39, z = 19, Z = 3.07, p =.059). Please see Figure 3 for the mean GM 
concentration of the relevant clusters for all groups and all time points. 
In addition, GM decreases were found in the left temporal pole and the left 
ventromedial prefrontal cortex. These GM changes were only visible in the n = 41 sample 
though. The contrast between baseline and day 12 in the overall patient sample (N = 77) 
additionally revealed decreased GM in the left inferior/medial temporal gyrus (Table 3). This 
was also visible in the n = 41 group (x = -62, y = -36, z = -20, Z = 4.08, p =.016) if analysed 
with a more relaxed statistical threshold (p < .001 (uncorrected) at voxel level and 
uncorrected at cluster level). In the n = 36 group, no significant GM decreases were visible. 
Overall, no GM increases from baseline to day 12 were visible in neither group. Neither GM 
increases nor decreases were found from baseline to day 90. 
(2) The correlation analyses between the difference images and the difference in the 
TQ/ loudness ratings revealed no significant results. 
(3) The correlation analyses between the TQ difference and the baseline images 
revealed a positive correlation of the TQ with GM concentration in the left medial temporal 
pole and the right posterior cingulate cortex in the n = 36 group (Table 3). The correlations in 
the n = 41 group did not reach statistical significance. Furthermore, in the overall patient 
group, a positive correlation between the TQ difference and the baseline images was found in 
the left and right lingual gyrus. Additionally, a marginally significant positive correlation was 
detected in the right inferior/middle frontal gyrus. Using a more relaxed statistical threshold 
(p < .05 (uncorrected) at voxel level and p < .05 FWE corrected at cluster level), a marginally 
positive correlation in the lingual gyrus (x = -4, y = -91, z = 13, Z = 3.78, p =.064) and in the 
inferior/middle frontal gyrus (x = 40, y = 44, z = 21, Z = 3.34, p =.093) was also found in the 
n = 41 group. 
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Figure 1. Line charts showing the time course of the TQ scores and loudness ratings for both 
independent subgroups and the overall group. Error bars represent the standard errors.  
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Figure 2. GM decreases from baseline to day 12 in (a) the right and left inferior frontal gyrus 
and (b) the insula bilaterally. (c) Positive correlation of the TQ difference with the GM 
concentration at baseline in the right frontal gyrus. R: right, L: left. 
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Figure 3. Mean GM concentration for each time point for the clusters with significant GM 
changes in (A) the subgroup of 41 patients, (B) the total group of 77 patients. For the clusters 
of (B) the mean GM concentration is also shown for the two independent subgroups. Error 
bars represent the standard deviations. 
  
 
Table 3 
Results of all VBM analyses 
Laterality Anatomical region Cluster size in voxels 
MNI coordinates 
 
Peak voxel 
Z-Score 
Cluster level 
p 
 
x y z  
GM decrease from baseline to day 12 (n = 41) 
L Temporal pole, Insula, Inferior frontal gyrus 1121 -56 8 -18  4.93 < .001  
R Insula (extending into temporal pole) 565 33 10 -18  4.79 .001  
R Inferior frontal gyrus 475 51 33 12  4.49 .009  
L Ventromedial prefrontal cortex 355 -4 52 -8  3.72 .026  
GM decrease from baseline to day 12 (n = 77) 
L Inferior frontal gyrus, Insula  1439 -46 12 -5  4.41 < .001  
R Insula (extending into temporal pole) 684 42 16 -11  4.44 .001  
R Inferior frontal gyrus 616 51 34 12  4.74 .001  
L Inferior/medial temporal gyrus 558 -57 -42 -17  4.21 .045  
Positive correlation of TQ difference with baseline images (n = 36) 
L Medial temporal pole 460 -32 6 -33  4.67 .014  
R Posterior cingulate cortex 430 6 -45 31  4.19 .036  
Positive correlation of TQ difference with baseline images (N = 77) 
R+L Lingual gyrus 534 4 -72 0  4.49 .037  
R Inferior/ middle frontal gyrus 413 52 30 19  3.86 .089  
Note. FWE-corrected at cluster level p < 0.05; L, left; R, right; MNI, Montreal Neurological Institute. 
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Discussion 
 In order to improve rTMS treatment for patients suffering from subjective tinnitus, it 
is of particular importance to understand the neural alterations rTMS induces in tinnitus 
patients’ brains in general – and in treatment responders’ brains in particular. The current 
study aimed at investigating the structural brain changes after rTMS treatment and the 
connection between these changes and clinical outcome. We examined GM alterations after 
10 sessions of low-frequency rTMS of the left temporal cortex. Besides the result that tinnitus 
severity and loudness were significantly reduced after rTMS treatment, the main findings of 
the present study were the following: 1) Transient GM decreases from baseline to day 12 
were observed in several cortical areas. Neither GM increases nor GM changes from baseline 
to day 90 were detectable. 2) There was no correlation between GM changes and clinical 
outcome. 3) GM images at baseline correlated with treatment outcome suggesting that GM at 
baseline might be related to treatment response. 
 
 GM changes from baseline to day 12. 
 Bilateral GM decreases from baseline to day 12 were detectable in the insula and the 
inferior frontal gyrus (IFG). Those results were identical in the n = 41 group and the overall 
patient sample. On a more relaxed statistical threshold, the GM decreases in the right inferior 
frontal cortex were also visible in the n = 36 group. As can be seen in Figure 3, this group 
also shows the tendency for GM decreases in both the right and left insula and frontal cortex. 
However, the difference is too small to reach statistical significance. Together with the 
anterior parts of the insula, the IFG is supposed to be a part of the ventral attention network 
(VAT) – a mostly right-lateralized network responsible for a stimulus-driven “bottom-up” 
reorientation of attention to salient stimuli (Corbetta, Patel, & Shulman, 2008). An altered 
connectivity between the VAT and the auditory and visual cortices in patients with 
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bothersome tinnitus has recently been shown (Burton et al., 2012). Furthermore, the insula 
has been reported to be part of a salience network (Seeley et al., 2007) and both the IFG and 
the anterior insula are supposed to be involved in conflict-processing (Roberts, K. L. & Hall, 
2008). If tinnitus is perceived as a permanent salient stimulus it continuously attracts 
attention and conflicts with other salient stimuli. It is therefore not surprising that as part of 
the VAT, alterations in the structure (Aldhafeeri et al., 2012) and function (Song, De Ridder, 
et al., 2012) of the IFG have been repeatedly reported in tinnitus research. While the insula is 
also a part of the VAT, it additionally plays an important role as part of a non-specific 
distress network (De Ridder et al., 2011). A relation between the insula and tinnitus distress 
has been consistently found in EEG-studies (van der Loo et al., 2011; Vanneste et al., 2010) 
and in studies examining structural brain alterations: Decreased GM volume in the insula was 
reported in highly distressed patients (Schecklmann et al., 2013) as well as a positive 
correlation between tinnitus distress and the cortical thickness in the anterior insula (Leaver 
et al., 2012). 
Notably, the GM decreases in the IFG and the insula seen in the current study were 
observed for the whole group independently of treatment outcome, indicating that these 
changes are rather related to the intervention than to its clinical effect. The same is true for 
the remaining GM decreases observed. While GM alterations in the left temporal pole and the 
ventromedial prefrontal cortex were only visible in the small sample and are therefore not 
further discussed, the GM decrease in the inferior and middle temporal gyrus was only seen 
in the overall sample and – on a more relaxed statistical threshold – in the n = 41 sample. 
Again, the n = 36 sample showed the same tendency (see Figure 3) but not in a significant 
degree. Similar to the IFG and the insula, the medial temporal cortex has been previously 
reported to show functional alterations in tinnitus patients (Song, De Ridder, et al., 2012; 
Vanneste, van de Heyning, & De Ridder, 2011). However, GM changes in the medial 
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temporal cortex might be rather linked to hearing loss than to tinnitus (Boyen et al., 2013) 
and the same might be true for the inferior temporal cortex. Again, the morphological 
changes observed in the current study are not correlated with changes in the TQ or loudness 
scores. These results clearly suggest that rTMS leads to GM changes indeed, but that these 
changes are an expression of ‘treatment’ rather than an expression of ‘treatment outcome’. 
All in all, those results are to be seen as preliminary and replications are clearly needed as the 
GM decreases were only statistically significant in the overall sample and one subsample but 
not in the second, smaller subgroup of 36 patients. 
Besides the GM decreases reported above, no GM increases were found from baseline 
to day 12 – a finding which is not in line with the results of May et al. (2007) who found GM 
increases in the left superior temporal area after 5 days of rTMS stimulation of the temporal 
cortex. The absence of such a GM increase in the current study is presumably not a problem 
of too little statistical power as it was neither found in the subsamples nor in the larger 
sample with 77 patients. One of the main differences between the current study and the study 
of May et al. is that the latter applied rTMS to healthy subjects while we used rTMS as a 
treatment for patients with subjective tinnitus. Maybe, tinnitus brains react differently to low-
frequency magnetic stimulation in comparison to control subjects. Knowing that there are 
both structural and functional alterations in the tinnitus brain in comparison to healthy 
controls (Adjamian et al., 2009; Lanting et al., 2009) and knowing that the effect of 1 Hz 
rTMS is state-dependent (Lefaucheur et al., 2012; Weisz, Steidle, & Lorenz, 2012) the 
different study outcomes might be reconcilable. 
 
 GM changes from baseline to day 90. 
 Interestingly enough, no GM decreases (nor increases) were seen from baseline to day 
90 which suggests that the decreases seen on day 12 are temporary in nature. This 
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observation is in line with the results of May et al. (2007) who also found that the changes 
induced by rTMS are transient. It remains to be seen at which point in time the regression of 
the GM changes happens exactly. Whether the observed transient nature of the rTMS effect 
on GM may also reflect a transiency of clinical effects of rTMS treatment should be explored 
in further studies. Notably, previous long-term follow-up investigations in tinnitus patients 
have suggested long-lasting effects over periods up to four years in the majority of rTMS 
responders (Burger et al., 2011; Khedr, Rothwell, & El-Atar, 2009). 
 
 GM changes and clinical outcome. 
 Obviously, rTMS treatment of the temporal cortex leads to alterations in cortical 
regions known to be important for subjective tinnitus. These alterations do not seem to 
directly cause change in tinnitus distress though. As we investigated 77 patients, the lacking 
correlations do probably not arise from too little statistical power. Rather, it has to be 
considered that VBM might not be a method sensitive enough to capture neural changes that 
are related to the slight change of tinnitus distress or loudness which can be obtained using 
rTMS. This might be different for TMS treatment protocols with larger treatment effects and 
this might also be different for neuroimaging methods more sensitive to function rather than 
structure – such as fMRI or EEG. The only study investigating functional changes induced by 
rTMS using fMRI measurements could in fact not detect a relationship between changes in 
brain activity and clinical outcome (Lefaucheur et al., 2012). However, with only six patients 
the study might have lacked the required power to detect such an effect. 
Taken together, the key message is that rTMS treatment of tinnitus patients affects 
brain structures different to the stimulation site which points to the importance of 
interconnections between distant cortical areas. It is well-known that TMS effects are not 
limited to the stimulated area and that functional changes can also be seen in remote cortical 
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brain areas (Bestmann & Feredoes, 2013; Siebner & Rothwell, 2003). What is true for 
functional changes might also be right for structural changes. While May et al. (2007) found 
GM increases in the stimulated area, they also reported the trend of GM increases in the 
temporal cortex contralateral to the stimulation site as well as in the thalamus bilaterally. 
Together with the results of the current study this emphasizes the importance of having in 
mind that magnetic stimulation of one cortical hotspot results in functional and presumably 
also structural alterations in a whole network of interconnected areas.  
In summary, the bilateral alterations in the IFG and insulae after rTMS – although not 
seen on a significant level in the n = 36 group subgroup – further support the notion of 
functional connectivity between the left temporal cortex and the VAT in tinnitus patients. 
Whereas rTMS induces transient alterations in these areas and also in the inferior and medial 
temporal cortex, these changes do not determine the clinical effects. 
 
 Baseline GM images as predictor for treatment outcome. 
 Concerning the question whether GM images can serve as predictors for treatment 
response, the current results suggest that there are some cortical areas in which patients who 
will benefit from rTMS treatment have less GM at baseline than patients who will not benefit. 
In the right IFG and the lingual gyrus bilaterally, a positive correlation between GM at 
baseline and the TQ change was detected which means that an improvement in the TQ 
(implicated by negative values) is related to less GM at baseline. These results were seen in 
the overall patient group and in tendency also in the n = 41 group. Though a positive 
correlation was also found in the left medial temporal pole and the right posterior cingulate 
cortex, these results were only visible in the n = 36 sample and are therefore not further 
discussed. As mentioned above, the right IFG is part of the VAT and important for attention 
shifts to salient stimuli. The question arises however, what “reduced GM volume in the right 
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IFG” actually means in terms of the function of the VAT. One could speculate that the VAT 
had been less sensitive to salient stimuli (e.g. the tinnitus) prior to rTMS treatment. As a 
consequence, a reduction of tinnitus severity might have been easier to accomplish in those 
patients. This is speculation though and – after replication – a challenging question for future 
research. The lingual gyrus has never been reported to play an important role for subjective 
tinnitus. However, functional and structural alterations in nearby occipital regions have been 
observed in tinnitus patients (Boyen et al., 2013; Maudoux et al., 2012), even if one of those 
studies suggests that GM decreases in occipital regions might be rather due to hearing loss 
than due to tinnitus (Boyen et al., 2013). Overall, these findings have to be considered as 
preliminary as the mentioned correlations reached statistical significance only in the overall 
patient group but not in the two independent subsamples. Therefore, replications are needed 
to confirm those results. Furthermore, there is some evidence that patients who benefitted 
from treatment once also benefit from a second treatment phase (Langguth, Landgrebe, 
Hajak, & Kleinjung, 2008; Mennemeier et al., 2008, 2013). For that reason, future studies 
should also try to shed light on the question whether there are characteristics in the brain 
which predispose an individual to benefit from rTMS treatment in general while others do 
not. 
 
 Limitations. 
 The current study has a number of limitations which should be considered in future 
studies. First, as just mentioned, hearing level was not available for all patients and could 
therefore not be integrated in the analyses. Although hearing loss is not supposed to be a 
predictor for response to rTMS treatment (Lehner et al., 2012), previous studies have shown 
that hearing loss is an important confounder concerning GM changes in tinnitus patients 
(Boyen et al., 2013; Husain et al., 2011; Melcher, Knudson, & Levine, 2013). To be able to 
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thoroughly interpret research results, future work should try to include pure tone audiogram 
including high-frequency audiogram (Boyen et al., 2013; Husain et al., 2011; Melcher et al., 
2013) for all patients. Second, the lacking correlation between treatment outcome and GM 
changes might have been due to the small treatment effects. As is already known from 
previous studies, the effect of rTMS treatment is small. Therefore, an even higher number of 
patients might have been necessary to ensure sufficient power for all analyses. The third and 
main limitation of the current study is the lack of a placebo condition. Without a patient 
group treated with sham stimulation we cannot definitely determine whether the observed 
GM changes were specific to rTMS treatment or unspecific effects. In the study of May et al. 
(2007), healthy control subjects showed no GM changes after sham rTMS as opposed to 
subjects treated with active rTMS. This finding has not been replicated for tinnitus patients 
yet. 
 
Conclusions 
 To the best of our knowledge this is the first study to combine clinical assessment and 
longitudinal structural MRI scans to measure rTMS effects in tinnitus patients. The major 
result of the study is that ten days of low-frequency rTMS treatment of the temporal cortex 
lead to transient GM decreases in cortical regions different from the stimulated area. This 
highlights the importance of considering that the brain is organised in networks and that this 
organisation highly influences the outcome of an intervention. Transient GM decreases were 
seen bilaterally in the insula, the IFG and the left inferior/middle temporal gyrus, indicating 
functional connectivity between the stimulation site in the left temporal cortex and the VAT 
in tinnitus patients. Although these cortical areas are known to be important in the generation 
and maintenance of tinnitus, the GM decreases were independent from treatment success. 
Thus, they were rather related to the TMS intervention per se, and not to its clinical effect. 
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However, treatment outcome correlated with GM at baseline indicating reduced GM in the 
right IFG and the lingual gyrus in patients benefiting from treatment. Thus, baseline GM 
images might hold potential to be further investigated as predictor for rTMS response in the 
future. 
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Abstract 
Low-frequency rTMS of the auditory cortex has been shown to significantly reduce tinnitus 
severity in some patients. There is growing evidence that a neural network of both auditory 
and non-auditory cortical areas is involved in the pathophysiology of chronic subjective 
tinnitus. Targeting several core regions of this network by rTMS might constitute a promising 
strategy to enhance treatment effects. This study intends to test the effects of a multisite 
rTMS protocol on tinnitus severity. Forty-five patients with chronic tinnitus were treated with 
multisite stimulation (left dorsolateral prefrontal, 2000 stimuli, 20 Hz; left temporoparietal, 
1000 stimuli, 1 Hz; right temporoparietal, 1000 stimuli, 1 Hz). Results were compared with a 
historical control group consisting of 29 patients who received left temporal stimulation 
(2000 stimuli, 1 Hz). Both groups were treated on ten consecutive working days. Tinnitus 
severity was assessed at three time points: at baseline, after the last treatment session (day 12) 
and after a follow-up period of 90 days. A change of tinnitus severity over time was tested 
using repeated measures ANOVA with the between-subjects factor treatment group. Both 
groups improved similarly from baseline to day 12. However, there was a difference on day 
90: The multisite stimulation group showed an overall improvement whereas patients 
receiving temporal stimulation returned to their baseline level of tinnitus severity. These pilot 
data suggest that multisite rTMS is superior to temporal rTMS and represents a promising 
strategy for enhancing treatment effects of rTMS in tinnitus. Future studies should explore 
this new protocol with respect to clinical and neurobiological effects in more detail. 
STUDY 2: MULTISITE RTMS FOR THE TREATMENT OF CHRONIC TINNITUS - A PILOT STUDY 
| 50  
 
Introduction 
 Subjective tinnitus is the perception of sound or noise without presence of an internal 
or external sound source. Affecting about 10–15 % of adults in general population samples 
(Hoffman, H. J. & Reed, 2004), tinnitus represents a highly prevalent condition which is 
often accompanied by psychological distress ranging up to comorbid depressive disorders, 
anxiety and sleeping problems (Langguth, 2011). As the neurobiological mechanisms of 
these phantom sounds are not yet completely understood, treatment of chronic subjective 
tinnitus proves to be difficult. However, within the last few years, new insights concerning 
neural alterations in chronic subjective tinnitus have been gained, which can now be used to 
develop innovative treatment approaches. Both animal studies (Roberts, L. E. et al., 2010) 
and neuroimaging studies in humans (Adjamian et al., 2009; Lanting et al., 2009) have shown 
tinnitus-related hyperactivity in the auditory cortex. Repetitive transcranial magnetic 
stimulation (rTMS) is able to influence cortical excitability and has successfully been used 
for the treatment of other hyperexcitability symptoms such as auditory hallucinations 
(Hoffman, R. E. & Cavus, 2002). It has therefore been introduced as a new treatment option 
for chronic subjective tinnitus several years ago (Eichhammer et al., 2003). In the meantime 
many clinical studies have examined the effects of five to 10 sessions of low-frequency rTMS 
on tinnitus severity. The majority of these studies demonstrated significant reductions of 
tinnitus severity after unilateral stimulation of the temporal or temporoparietal cortex in some 
patients (Plewnia, 2011). Although these findings are considered promising, the results are 
burdened by only small to moderate effect sizes and large inter-individual variability. Thus 
optimization strategies are to be found to enhance the efficacy of this innovative treatment 
approach. 
Recent results from imaging studies indicate that in tinnitus patients alterations of 
neural activity are not restricted to the auditory cortex but have also been observed in non-
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auditory cortical areas. For instance, the reduction of tinnitus loudness after administration of 
lidocaine results in reduced regional cerebral blood flow in temporal as well as frontal, 
parietal and limbic areas (for a review see Lanting et al., 2009). Furthermore, 
magnetoencephalographic measurements have shown that in tinnitus patients spontaneous 
neural activity in both temporal and frontal cortices is characterized by a decrease in alpha 
power and an enhancement in delta and gamma power (Weisz et al., 2005, 2007). These 
activity changes in auditory and non-auditory structures seem to be related to each other as 
recent studies suggest that also the functional connection between those areas plays a crucial 
role in subjective tinnitus. Schlee, Hartmann et al. (2009) applied resting-state MEG to 
analyze the connectivity between temporal, parietal, frontal and cingulate cortices in tinnitus 
patients and healthy controls. In tinnitus patients a decreased connectivity between those 
areas in the alpha band as well as increased inter-areal coupling in the gamma frequency 
range was found. Furthermore, the gamma network turned out to be more widespread in 
patients who had been experiencing their tinnitus for more than four years. Those results 
indicate that a network consisting of functionally connected auditory and non-auditory 
structures is involved in the development and the chronic manifestation of subjective tinnitus. 
These data do not only provide an explanation for the limited effects of past studies 
examining single-site rTMS for the treatment of chronic tinnitus but also offer a starting point 
for strategies to enhance treatment effects. If a network of several cortical areas forms the 
neural basis for chronic tinnitus, stimulation of the auditory cortex might not be sufficient to 
achieve a long lasting improvement of tinnitus severity. An extension of rTMS stimulation to 
non-auditory areas might therefore represent a good strategy to optimize treatment effects. 
There are promising results from a pilot study which compared standard low-frequency left 
temporal stimulation to a combined stimulation protocol (high-frequency left dorsolateral 
prefrontal plus low-frequency left temporal stimulation, Kleinjung et al., 2008). Immediately 
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after ten days of treatment no difference in the efficacy of both stimulation protocols was 
observed. After a follow-up period of three months, however, patients in the ‘combined 
stimulation’ group showed a more pronounced overall symptom improvement than patients 
who had been treated with left temporal stimulation. The superior long term effects of 
combined stimulation were confirmed by a recent retrospective study with larger sample sizes 
(Lehner et al., 2012). Based on these studies and the knowledge about altered functional 
connectivity between auditory and non-auditory brain regions, we hypothesized that 
treatment effects can be enhanced if the whole network (Schlee, Hartmann, et al., 2009) is 
targeted by rTMS. Here we aimed to test a new stimulation protocol which covers a majority 
of the central hubs of increased tinnitus related connectivity. Since this network comprises 
temporal, parietal, frontal and cingulate brain regions all of which can be stimulated with a 
varying number of stimuli and frequencies, there are many possibilities of how an optimal 
stimulation protocol could look like. We chose a multisite protocol, which combined high-
frequency stimulation of the left dorsolateral prefrontal cortex (DLPFC) and bilateral low-
frequency stimulation of the temporoparietal cortices for several reasons. High-frequency 
stimulation over the DLPFC has been shown to mediate activity changes in the anterior 
cingulate cortex via functional connections between the DLPFC and the anterior cingulate 
cortex (Speer et al., 2000). Furthermore, combined stimulation of the left DLFPC and left 
temporal cortex has already been successfully applied to tinnitus patients with combined 
stimulation resulting in more pronounced treatment effects than temporal stimulation alone 
(Kleinjung et al., 2008). The decision to treat temporoparietal cortices over both hemispheres 
was based on two ideas. (a) Four core regions of the tinnitus network (bilateral temporal and 
parietal) could be reached by stimulating only two areas (bilateral temporoparietal, Tracy et 
al., 2010). (b) Furthermore, results from past studies about low-frequency rTMS over the 
temporoparietal cortex are ambiguous concerning the question of which hemisphere to treat. 
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While some studies suggest that stimulation over temporoparietal cortex contralateral to the 
tinnitus percept is superior to ipsilateral stimulation (Khedr et al., 2010), other studies 
indicate that stimulation of the left temporoparietal cortex is effective irrespective of tinnitus 
laterality (Khedr, Rothwell, Ahmed, & El-Atar, 2008; Rossi et al., 2007). These conflicting 
results bear an uncertainty of targeting the appropriate hemisphere – a problem which could 
be avoided by bilateral stimulation of both temporoparietal cortices. The objective of the 
current pilot study was to obtain a first estimate of this new protocol’s effectiveness in order 
to find out if the idea of network stimulation should be explored in more detail in the future. 
 
Materials and Methods 
 Subjects and rTMS treatment. 
 Data from 74 patients were analysed. All patients had suffered from disturbing 
tinnitus for at least three months. Forty-five patients (31 men, 14 women, mean age 53.54 ± 
12.82 years) (all data in the text and tables are given as mean ± standard deviation) were 
treated with the multisite stimulation protocol which consisted of high-frequency stimulation 
of the left DLFPC (20 Hz, 2000 stimuli/day) followed by left and right temporoparietal 
stimulation (1 Hz, 1000 stimuli/day over each hemisphere), resulting in 4000 stimuli/day and 
40.000 stimuli in total. The sequence of stimulation was the same for all patients (DLPFC 
first, then left and then right temporoparietal cortex). As the treatment protocol was examined 
for the very first time, we intended to gather pilot data and test the safety and feasibility of 
the new protocol. Therefore, data were collected in a one-arm open label study from February 
to November 2011. 
 For a preliminary comparison with left temporal rTMS we used a historical control 
group consisting of 29 patients (23 men, 6 women, mean age 46.48 ± 15.09) who had been 
treated with 1 Hz stimulation over the left temporal cortex (2000 stimuli/day, 20.000 stimuli 
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in total) in the course of a former study between August 2009 and April 2011 (Kreuzer et al., 
2011). 
 All participants received 10 sessions of rTMS on ten consecutive working days at the 
Tinnitus Center at the University of Regensburg, Germany. Both groups met identical 
inclusion and exclusion criteria (see Table 4). Demographical and clinical data of both groups 
were comparable except for age and baseline scores for THI (Tinnitus Handicap Inventory) 
and Beck’s Depression Inventory (BDI) with the multisite group being older and scoring 
higher on the THI and BDI (see Table 5). Additionally, the multisite group tended to score 
higher in two rating scales (strong/ loud and ignoring). Many patients were treated with 
centrally acting drugs (for detailed information see Table 6). The medication was kept 
constant in all cases during the stimulation period and in almost all patients throughout the 
follow-up period. All patients provided written informed consent after comprehensive 
explanation of the procedures. 
 For both treatment protocols, a Medtronic system with a figure-of-eight coil (Cool B-
65 Butterfly, Medtronic, Minneapolis, MN, USA) was used. Stimuli were applied with an 
intensity of 110% RMT but never higher than 60% of maximal stimulator output. RMT was 
defined as the minimal intensity at which at least five of ten motor evoked potentials were 50 
µV in amplitude in the right M. abductor digiti minimi. Temporal and temporoparietal 
cortices were localized by using the 10-20 localization system (Hoffman, R. E. et al., 2000; 
Jasper, 1958; Langguth et al., 2006). The DLPFC was localized by centring the coil 6 cm 
anterior from the part of the motor cortex that had already been targeted for defining the 
RMT (Frank, E. et al., 2011). Both treatment protocols had been approved by the local ethics 
committee. 
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 Clinical assessment. 
 For the assessment of demographical and clinical characteristics patients completed 
the Tinnitus Sample Case History Questionnaire (Langguth et al., 2007) when they visited the 
Tinnitus Center for the first time during tinnitus consultation hours. Hearing level [dB HL] is 
reported as an average of all thresholds measured bilaterally in pure-tone audiogram ranging 
from 125 Hz to 8 kHz. Tinnitus severity was assessed by the German versions of the TQ 
(Goebel & Hiller, 1994), the THI (Kleinjung, Fischer, et al., 2007; Newman, Jacobson, & 
Spitzer, 1996) and five additional items which measured (a) how loud, (b) uncomfortable, (c) 
annoying or (d) unpleasant tinnitus was perceived and e) how easily it could be ignored. 
Those items were rated on a numeric scale ranging from 0 to 10 with higher values indicating 
a more severe tinnitus. For assessment of depressive symptoms patients completed the BDI 
(Beck & Steer, 1984). These psychometric measures were assessed at three time points 
during the study: at baseline (immediately before treatment beginning), at the end of 
treatment (day 12) and after a follow-up period of three months (day 90). 
 
 Statistical analysis. 
 For statistical analyses PASW statistics 18 (SPSS Inc., Chicago, IL) was used. All 
data were entered into the database of the Tinnitus Research Initiative (Landgrebe et al., 
2010). Data management was conducted according to the Data Handling Plan (TRI-DHP 
V07, 09.05.2011). Data analysis was conducted according to the Standard Operating 
Procedure (TRI-SA V01, 09.05.2011) thereby following a study-specific Statistical Analysis 
Plan (SAP) that was written according to the SAP template (TRI-SAP 007, 09.02.2012). All 
documents can be accessed under (http://database.tinnitusresearch.org/). Missing values were 
replaced by using a last observation carried forward (LOCF, or if this was not possible 
backward) procedure. Two baseline-scores for the TQ and one for the BDI and the rating 
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scale strong/ loud were missing. For day 12, two scores were missing for the THI and one for 
all other variables measured. For day 90, ten scores had to be replaced for the TQ, nine for 
the THI and eight for all other variables (drop-outs on day 90). 
To test for changes in tinnitus severity from baseline to day 12 and day 90, an 
ANOVA with within-subjects factor time (baseline, day 12, day 90) and between-subjects 
factor group (left temporal vs. multisite stimulation) was calculated for all eight variables 
(TQ, THI, BDI, five rating scales). In order to find out if the group differences in age and 
some of the baseline values of tinnitus severity (see Table 5) exerted an influence on the 
results, two additional analyses were conducted: First, an analysis of covariance (ANCOVA) 
was done with age, the baseline scores for the THI, BDI and the two rating scales 
“uncomfortable” and “ignoring” being entered as covariates. Second, we created matched 
groups by selecting 25 patients of each group which were matched for all variables measured 
(all group comparisons had a p-value of ≥ .11) and which were then compared using an 
ANOVA. 
All further analyses were then based on the ANOVA which was done for all 74 
patients. If no significant interaction effect resulted, no further analysis was carried out for 
the respective variable. In case of significant interaction effects, different post-hoc tests were 
calculated. For the within-group comparisons of tinnitus severity, groups were analysed 
separately by using paired t-tests (baseline vs. day 12, baseline vs. day 90, day 12 vs. day 90). 
For the between-group comparisons, difference values were calculated for each pair of time 
points (e.g., TQ on day 12 minus TQ at baseline) with negative values indicating an 
improvement in time. Those difference values of both groups were then used for the between-
group comparisons with independent sample t-tests. Finally, responder rates were calculated 
with responders defined as patients having improved by five points or more in the TQ score 
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(Adamchic et al., 2012; Frank, G. et al., 2010; Kleinjung, Steffens, et al., 2007). Responder 
rates were then compared between groups by using a Chi² test. 
 Former studies suggest that adding more stimulation sites results in better long-term 
effects of rTMS treatment (Kleinjung et al., 2008; Lehner et al., 2012). A better long-term 
effect is therefore expected for the multisite protocol as well. However, as the treatment 
groups in the current study differed both in the number of stimuli and in the number of 
stimulation sites, the question arises which of the two parameters is responsible if better long-
term effects are observed. To provide a first answer to this question, a third group of patients 
(N = 193) was added to the analysis who received the same number of stimuli as the multisite 
group (4000 stimuli/day) but over two stimulation sites instead of three (110% motor 
threshold, 2000 stimuli at 20 Hz over left dorsolateral prefrontal cortex plus 2000 stimuli at 1 
Hz over temporal cortex). Details on this group have been reported elsewhere (Lehner et al., 
2012). An ANOVA with within-subjects factor time (baseline, day 90) and between-subjects 
factor group (left temporal vs. multisite stimulation vs. temporal plus frontal stimulation) was 
calculated for the TQ which was the only outcome parameter available for the third group. 
Independent sample t-tests were used as post-hoc tests with the TQ changes (score on day 90 
minus score on baseline) as dependent variable. All statistical tests were two-tailed and 
unadjusted for multiple comparisons following a pilot study approach. The level of 
significance was set at .05. 
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Table 4 
Inclusion and exclusion criteria for both treatment groups 
Inclusion criteria Exclusion criteria 
 Age older than 18 years 
 Subjective chronic tinnitus 
 Duration of tinnitus more than 3 months 
 Contraindication for rTMS (epilepsy, 
cardiac pacemaker, head injury, evidence 
of significant brain malformation or 
neoplasm, cerebral vascular events, 
neurodegenerative disorder affecting the 
brain or prior brain surgery, metal objects 
in and around the body that cannot be 
removed, pregnancy) 
 Objective tinnitus 
 Treatable cause of the tinnitus 
 Involvement in other treatments for 
tinnitus at the same time 
 Clinically relevant psychiatric 
comorbidity 
 Clinically relevant unstable internal or 
neurological comorbidity 
 Alcohol or drug abuse 
 Prior treatment with rTMS 
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Table 5 
Demographical data and clinical characteristics for both treatment groups 
 left temporal 
rTMS (N = 29) 
multisite rTMS 
(N= 45) 
group comparison 
       p 
Gender M (79 %) 
F (21 %) 
M (69 %) 
F (31 %) 
χ2(1, 74) = 0.97 .324 
Age (years) 46.48  ± 15.09 53.54 ± 12.82 t(72) = -2.15 .035* 
Hearing threshold 
[dB HL] 
19.58 ± 13.69 21.16 ± 12.55 t(72) = -0.51 .610 
tinnitus laterality right (14 %) 
left (10 %) 
both ears (76 %) 
right (7 %) 
left (11 %) 
both ears (82 %) 
χ2(2, 74) = 1.05 .593 
Tinnitus duration 
(years) 
7.11 ± 6.41 8.34 ± 7.34 t(72) = -0.74 .464 
Tinnitus severity (baseline): 
   
TQ 39.03 ± 18.03 44.98 ± 16.09 t(72) = -1.48 .14 
THI 40.55 ± 20.15 51.47 ± 22.33 t(72) = -2.13 .037* 
BDI 8.55 ± 7.47 12.27 ± 6.61 t(72) = -2.24 .028* 
Strong/ loud  6.48 ± 2.17 6.76 ± 1.77 t(51.33) = -0.57 .57 
Uncomfortable 6.76 ± 2.20 7.64 ± 1.71 t(49.27) = -1.84 .072
#
 
Annoying 6.48 ± 2.36 6.87 ± 1.90 t(72) = -0.77 .44 
Unpleasant 6.48 ± 2.15 6.62 ± 2.08 t(72) = -0.28 .78 
Ignoring 6.28 ± 2.51 7.24 ± 2.06 t(72) = -1.81 .074# 
Note. *α < .05; #α < .10.
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Table 6 
Centrally acting medication for both treatment groups (number of patients treated with each 
drug are specified in brackets) 
 Left temporal rTMS (N = 29) Multisite rTMS (N = 45) 
Antidepressants Opipramol (1) Opipramol (2) 
 Agomelatine (1) Agomelatine (8) 
 Mirtazapin (2) Mirtazapin (6) 
 Duloxetin (1) Duloxetin (1) 
 Venlafaxin (1) Citalopram (3) 
  Escitalopram (1) 
  Trimipramin (1) 
  Bupropion (1) 
  Amitriptylin (3) 
  Doxepin (2) 
  Lithium (1) 
Anticonvulsants Pregabalin (2) Pregabalin (2) 
 Carbamazepin (1)  
Neuroleptica Quetiapin (1) Quetiapin (2) 
  Risperidon (1) 
Others Gingko (1) Gingko (2) 
 Zopiclon (1) Sifrol (2) 
 Metoprolol (1) Metoprolol (3) 
 Baclofen (1) Bisoprolol (4) 
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Results 
 Adverse events. 
 Both the left temporal and the multisite stimulation protocol were well tolerated by 
the patients. No serious adverse effects were observed. Five patients in the multisite group 
complained about transient headache as a side effect. One patient reported an elevated 
loudness of his tinnitus. All side effects recovered within the observation period and were 
comparable to those seen in the group treated with left temporal rTMS (eight patients 
reported headache, three reported elevated loudness of the tinnitus). No patient dropped out 
of the study during the treatment phase, but a total of eight patients did not show up for the 
final visit on day 90, five of them being in the multisite group (drop-outs on day 90).  
 
 Statistical analysis. 
 ANOVAs revealed a significant interaction effect between time and group for six of 
the eight variables analysed (see Table 7). No significant interactions were found for THI and 
BDI. Those variables were therefore not included in the following analyses. However, on a 
descriptive level those variables showed a comparable pattern to the variables with significant 
effects. 
For left temporal rTMS within-group comparisons with post-hoc paired t-tests 
revealed significant to marginally significant changes from baseline to day 90 for the rating 
scales “strong/ loud”, “ignoring” and “unpleasant” (see Table 8). The difference from day 12 
to day 90 was significant to marginally significant for all rating scales, which were entered 
into the post-hoc tests. As can be seen in Figure 4, both the changes from baseline to day 90 
and day 12 to day 90 were due to a worsening of the tinnitus. For multisite rTMS, the change 
from baseline to day 12 was significant for the TQ and the rating scale “uncomfortable”. The 
changes from baseline to day 90 were significant to marginally significant for the TQ and 
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three of the rating scales (see Table 8). The change from day 12 to day 90 was only 
significant for the rating scale “unpleasant”. For the multisite rTMS group all significant 
changes were due to an improvement in tinnitus severity (see Figure 4). 
 Between-group comparisons revealed that the change in tinnitus severity from 
baseline to day 12 was comparable between both treatment groups as no comparison reached 
statistical significance (see Table 9). However, changes from baseline to day 90 and from day 
12 to day 90 were significantly different between groups for all variables entered into the 
between-group comparisons. To control for the group differences an ANCOVA and an 
ANOVA for matched groups were calculated. In comparison to the ANOVA including all 74 
patients, the results reveal some differences between the tests (see Table 7) but do not suggest 
systematic changes caused by age or tinnitus severity. With respect to the responder rates, 
there was no difference between groups on day 12 (31% in the left temporal stimulation 
group, 49 % in the multisite stimulation group, χ2(1, N = 74) = 2.31, p = .13). On day 90, the 
responder rates differed however (20% in the temporal stimulation group, 49% in the 
multisite stimulation group, χ2(1, N = 74) = 5.96, p = .015). The ANOVA comparing the TQ 
changes on day 90 between multisite stimulation, left temporal stimulation and left temporal 
plus left frontal stimulation revealed an marginally significant interaction effect between time 
and treatment (F(2, 226) = 2.99, p = .052). Post-hoc t-tests showed a significant difference 
between multisite and left temporal stimulation (t(72) = -2.23, p = .029), a marginally 
significant difference between left temporal and temporal plus frontal stimulation  
(t(182) = -1.95, p = .053) and no significant difference between multisite and temporal plus 
frontal stimulation (t(198) = -1.20, p = .23). Figure 5 shows the TQ scores for all three time 
points and all three groups. 
 
 
  
 
Table 7 
Results from two-way repeated measures analyses of variance: interaction effects (time  x group) 
 ANOVA  ANCOVA
+
  ANOVA matched groups 
 F (df) p  F (df) p  F (df) p 
TQ 4.05 (1.47, 105.65) .032*  2.32 (1.44, 96.52) .12  2.73 (1.51, 72.29) .086
#
 
THI 3.10 (1.47, 105.74) .065
#
  1.56 (1.48, 98.96) .22  3.58 (1.58, 75.96) .043* 
BDI 1.07 (1.78, 128.01) .34  0.19 (1.80, 120.69) .80  3.16 (2, 96) .047* 
Ratings:         
strong/ loud  4.28 (1.79, 129.07) .019*  3.04 (1.82, 122.18) .056
#
  2.46 (2, 96) .091
#
 
uncomfortable 4.24 (1.76, 126.93) .020*  4.45 (1.84, 123.38) .016*  5.97 (1.76, 84.55) .005* 
annoying 3.97 (1.71, 123.35) .027*  2.50 (1.73, 115.67) .095
#
  1.56 (2, 96) .22 
ignoring 5.35 (2, 144) .006*  3.44 (2, 134) .035*  4.60 (2, 96) .012* 
unpleasant 4.12 (1.82, 130.67) .022*  3.16 (1,82, 122.12) .050*  3.32 (2, 96) .040* 
Note. *α ≤.05; # α < .10; +Covariates: age and baseline scores for THI, BDI, uncomfortable and ignoring. 
 
  
 
Table 8 
Results from post-hoc tests: paired t-test for within-group comparisons 
 left temporal rTMS (df = 28)  multisite rTMS (df = 44) 
 12 - baseline  90 - baseline  90 - 12  12 - baseline  90 - baseline  90 - 12 
 t p  t p  t  p  t p  t p  t p 
TQ 0.98 .34  -0.98 .34  -1.62 .12  2.29 .027*  2.32 .025*  1.25 .22 
strong/ loud 0.92 .38  -1.85 .074
#
  -2.34 .027*  0.77 .45  1443 .16  1.27 .21 
uncomfortable 0.92 .37  -0.75 .46  -1.75 .092
#
  2.69 .010*  2.88 .006*  1.22 .23 
annoying 0.22 .83  -1.60 .12  -1.98 .057
#
  1.03 .31  1.82 .076
#
  1.66 .10 
ignoring 0.61 .55  -2.37 .025*  -2.74 .011*  1.46 .15  2.01 .050*  0.93 .36 
unpleasant 0.68 .50  -1.71 .096
#
  -2.19 .037*  -0.63 .55  1.06 .30  2.53 .015* 
Note. *α < .05; #α < .10.
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Table 9 
Results from post-hoc tests: independent samples t-test for between group comparisons 
(df = 72) 
 12 - baseline  90 - baseline  90 - 12 
 t p  t p  t p 
TQ 0.87 .39  2.23 .029*  2.04 .045* 
strong/ loud -0.09 .93  2.31 .024*  2.75 .007* 
uncomfortable 1.10 .28  2.64 .010*  2.13 .037* 
annoying 0.51 .61  2.42 .018*  2.61 .011* 
ignoring 0.51 .61  2.87 .005*  2.76 .007* 
unpleasant -0.88 .38  1.70 .093
#
  3.33 .001* 
Note. *α < .05; #α < .10. 
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Figure 4. Point diagrams showing the relative changes of TQ scores and rating scales from 
baseline to day 12 / day 90 for both groups separately (M ± SE, negative values describe an 
improvement of tinnitus severity). 
 
 
 
 
 
STUDY 2: MULTISITE RTMS FOR THE TREATMENT OF CHRONIC TINNITUS - A PILOT STUDY 
| 67  
 
 
 
 
 
 
Figure 5. Line chart showing the time course of the TQ for both treatment groups in 
comparison to a group receiving left temporal plus left frontal rTMS. 
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left temporal + frontal
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Discussion 
 The current study aimed to make a rough estimate of the safety, feasibility, 
tolerability and effectiveness of a new stimulation protocol which was designed on the basis 
of the tinnitus network as described by Schlee, Hartmann et al. (2009). The main finding of 
this study is that ten days of rTMS treatment with this new multisite stimulation protocol 
resulted in a reduction of tinnitus severity that outlasted the follow-up period of 90 days. This 
long-term improvement appears especially prominent if compared to the control group, which 
was treated over the left temporal cortex only. In the short run (day 12), both protocols 
caused a similar improvement of tinnitus severity. In the control group, this improvement was 
rather short-lasting however, with tinnitus severity returning to its baseline level on day 90. 
Therefore, no improvement was detectable from baseline to day 90 in this group. In contrast, 
in the multisite stimulation group tinnitus severity remained largely stable from day 12 to day 
90 with even some further (but mostly non-significant) improvement, resulting in an overall 
significant improvement of tinnitus severity from baseline to day 90. Responder rates on day 
12 and day 90 underpin these results with both groups having similar responder rates on day 
12 but significantly higher responder rates in the multisite stimulation group on day 90. 
These results are in line with the results of Kleinjung et al. (2008) who compared left 
temporal stimulation to a combined frontal plus left temporal stimulation. Similar to the 
current results, both protocols were similarly effective on day 12 whereas on day 90, 
combined stimulation was slightly superior to left temporal stimulation. This superiority did 
not reach statistical significance though, whereas the multisite protocol of the current study 
turned out to be significantly superior. However, in the current study the patients receiving 
left temporal stimulation were treated with 2000 stimuli/day whereas patients receiving 
multisite stimulation were treated with 4000 stimuli/day. Therefore the question arises 
whether the superior long-term effect of the multisite protocol is due to the higher number of 
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stimuli or due to the fact that more stimulation sites were treated. There is evidence that the 
effect of rTMS might be dose-dependent with more stimuli resulting in more tinnitus 
reduction (Plewnia et al., 2007). However, this has only been shown in single sessions of 
rTMS so far and currently no study has examined if the long-term outcome of rTMS 
treatment in tinnitus patients is dose-dependent as well. Nevertheless, it cannot be ruled out 
that multisite stimulation was superior to left temporal stimulation only because of the higher 
number of stimuli. For this reason, another historical control group was added to the analysis. 
Those patients were treated with 4000 stimuli/day over two stimulation sites. The comparison 
of the long-term effects for all three groups suggests that both the higher number of stimuli 
and the higher number of stimulation sites add to the better long-term effects of the multisite 
protocol (see Figure 5). Although TQ changes on day 90 do not differ significantly between 
multisite and temporal plus frontal stimulation, the difference between multisite and left 
temporal stimulation is significant indeed while the difference between left temporal plus 
frontal and left temporal stimulation is only marginally significant. Therefore, a large portion 
of the superiority of the multisite over the left temporal protocol might be due to a larger 
amount of stimuli but it also seems to matter, where these stimuli are applied (see Figure 5). 
It has to be considered however that this is an exploratory study and that this result should be 
interpreted with caution. Future studies applying a dose-matched control protocol with 
randomized group allocation and using multiple outcome parameters should try to replicate 
the results. 
We are well aware about the limitations of the present study. Due to the exploratory 
nature of this pilot study, our findings have to be considered preliminary and need 
confirmation by randomized controlled trials. Because of the exploratory purpose of this pilot 
study, the various dependent variables were analysed separately without adjusting for 
multiple comparisons. Moreover results were compared with a historical control group. Even 
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if all patients of both the multisite and the left temporal group met identical inclusion and 
exclusion criteria (Table 4) and even if the treatment was performed in both groups at the 
same institution and by the same team a group-specific selection bias cannot be excluded. 
Groups differed in their concomitant medication though. However, in all patients medication 
was kept constant during the treatment period and in most of the patients also during the 
follow-up period. Therefore, no systematic variation of drugs took place. Although we cannot 
exclude the possibility that some drugs might have had an additional effect on treatment 
outcome or might have interacted with rTMS treatment, neither our data nor former studies 
(Kleinjung et al., 2009, 2011) do indicate such effects. 
Also, there were group differences regarding age and some of the baseline measures 
of tinnitus severity which might have affected treatment outcome. We tried to control for 
those differences by including the variables concerned as covariates and by creating matched 
groups. The results suggest that the effect of multisite stimulation being superior to left-
temporal rTMS is rather stable and largely independent of those group differences. 
Nevertheless, replication of the results using a study design with randomized group allocation 
is necessary to confirm the results of the current study. 
Despite these limitations the assumption that multisite stimulation is able to disrupt 
altered activity within the tinnitus network and thereby leads to an improvement of tinnitus 
severity constitutes a plausible explanation for its better long-term effects. The auditory and 
the non-auditory areas are supposed to assume different roles concerning the tinnitus percept 
(De Ridder et al., 2011). Therefore, different outcomes would be expected depending on if 
the auditory cortex is stimulated exclusively or if non-auditory areas are stimulated in 
addition. As activity in the auditory cortex is correlated with tinnitus loudness (van der Loo et 
al., 2009) it can be speculated that the loudness of the sound might be coded in auditory 
structures whereas the involvement of non-auditory brain areas is considered essential for 
STUDY 2: MULTISITE RTMS FOR THE TREATMENT OF CHRONIC TINNITUS - A PILOT STUDY 
| 71  
 
conscious perception of this sound. According to Dehaene and Changeux (2004), a conscious 
auditory percept requires activity of a “global workspace” in form of a fronto-parieto-cingular 
network which is assumed to modulate the activity in sensory cortices via top-down 
amplification or inhibition (Dehaene & Changeux, 2004). Consequently, left temporal 
stimulation might be able to influence activity within the auditory cortex and therefore result 
in a temporary improvement of tinnitus severity. But as the altered top-down influence of the 
global workspace may still be present, the activity within the auditory cortex might be 
elevated again (Schlee et al., 2011), causing a rebound of tinnitus severity to its baseline 
level. In contrast, multisite stimulation targets both the auditory cortex and the global 
workspace on several central nodes, possibly resulting in a disruption of the whole network 
and consequently in a long-term improvement of tinnitus severity. 
Results from the study of Schlee, Mueller et al. (2009) suggest that this top-down 
modulation might in fact play a role in chronic tinnitus. They found that in tinnitus patients 
the prefrontal cortex serves as an important cortical hub, which exerts strong influence on 
other cortical regions whereas the temporal cortex is a core region as well but is strongly 
influenced by other brain regions. Moreover, this external modulation of the temporal cortex 
was positively correlated with tinnitus distress: The more the temporal cortex was driven by 
other areas, the more distress was reported by the patients. 
After all, this explanation of a successfully disrupted tinnitus network as a reason for 
more pronounced long-term effects of multisite stimulation remains speculative, of course. In 
order to clarify this issue future research should combine rTMS treatment with functional 
neuroimaging methods and compare functional alterations that appear after left temporal vs. 
after multisite stimulation. If multisite stimulation interferes with the tinnitus network 
whereas left temporal stimulation does not, different functional changes should be detectable.  
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Instead of altered network activity being the reason for the observed results of this 
pilot study there is also the possibility of single stimulation sites being responsible for the 
better long-term effect of multisite stimulation. For instance, high-frequency stimulation of 
the left DLPFC is well known to exert antidepressant effects (Gross, Nakamura, Pascual-
Leone, & Fregni, 2007). As tinnitus patients do often suffer from comorbid depression 
(Langguth, 2011) it is possible that patients felt less bothered by their tinnitus or could better 
cope with it due to an improvement of their depressive symptoms. This explanatory approach 
is considered unlikely though as no significant interaction effect between time and group 
concerning the BDI was observed. This indicates that depressive symptoms did not change 
differently after treatment with multisite or with left temporal stimulation, respectively. This 
would have been expected though if depressive symptoms were responsible for the better 
long-term effects of multisite stimulation. Therefore, the superiority of the applied multisite 
stimulation paradigm cannot be ascribed to a sole reduction of depressive symptoms. 
Bilateral stimulation over temporoparietal cortices alone is also highly unlikely to be 
responsible for the observed effect, since two recent studies (Hoekstra et al., 2012; Plewnia et 
al., 2012) did not find tinnitus reduction after bilateral stimulation of the temporal or 
temporoparietal cortices. 
In this study, a stimulation protocol was designed which was assumed to have great 
potential to represent a clinically effective treatment for tinnitus patients. With the clinical 
effectiveness being our primary goal the most promising treatment protocol was used right 
away without testing different protocols consisting of only two stimulation sites beforehand. 
Thus, no definite answer can be given regarding the question which of those possible 
mechanisms is finally responsible for the longer lasting effects of multisite stimulation 
compared to left temporal stimulation. 
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All in all, this study was conducted to obtain an estimate of the effectiveness, 
feasibility and safety of the new protocol in order to find out if the idea of network 
stimulation should be further explored in future studies. The multisite protocol turned out to 
be feasible in clinical routine and was well tolerated by all patients. As the protocol caused 
only slight side effects (like transient headache) which are already known from low-
frequency temporal stimulation, our data suggest that the multisite protocol is as safe as the 
well-known temporal stimulation protocol. Additionally, the pilot data show promising long-
term effects of the multisite stimulation indeed. Subsequent studies are now needed to 
analyse both clinical and neurobiological effects of this new stimulation paradigm in more 
detail. Those studies should take the limitations of the current trial into account by using 
randomized group allocation, by matching the number of stimuli in both treatment groups and 
by including measures of neurobiological changes to allow for an analysis of the neural 
changes different treatment protocols are inducing in tinnitus brains. 
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Abstract 
Recent research indicates that tinnitus is related to alterations of neural networks including 
temporal, parietal, and prefrontal brain regions. The current study examines a rTMS protocol 
which targets three central nodes of these networks in a two-arm randomized parallel group 
trial. Overall, 49 patients with chronic tinnitus were randomized to receive either triple-site 
stimulation (left DLPFC stimulation, 1000 pulses, 20 Hz plus left and right temporoparietal 
stimulation, 1000 pulses each, 1 Hz) or single-site stimulation (left temporoparietal 
stimulation, 3000 pulses, 1 Hz). Both groups were treated in 10 sessions. Tinnitus severity as 
measured by the TQ was assessed before rTMS (day1), after rTMS (day12) and at two 
follow-up visits (day 90 and day 180). The triple-site protocol was well tolerated. There was 
a significant reduction in tinnitus severity for both treatment groups. The triple-site group 
tended to show a more pronounced treatment effect at day 90. However, the measurement 
time point x group interaction effect was not significant. The current results confirm former 
studies that indicated a significant reduction of tinnitus severity after rTMS treatment. No 
significant superiority of the multisite protocol was observed. Future approaches for the 
enhancement of treatment effects are discussed. 
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Introduction 
 Chronic subjective tinnitus is defined as the perception of sound or noise without 
presence of a corresponding internal or external sound source. It is a highly prevalent 
(Hoffman, H. J. & Reed, 2004) and for many patients very stressful condition which impairs 
their everyday lives and mental well-being (Langguth, 2011). There is no cure for tinnitus yet 
and the development of effective causally oriented treatment options is highly dependent on a 
more detailed understanding of tinnitus pathophysiology. Traditionally, tinnitus research 
focused on the peripheral and central auditory system (Eggermont & Roberts, 2004) but in 
the past years, it has shifted to a more global perspective also considering non-auditory 
cortical areas (Adjamian et al., 2009; De Ridder et al., 2011; Lanting et al., 2009). It has been 
shown that tinnitus is accompanied by alterations of functional connectivity within and 
between several neural networks including temporal, parietal and frontal cortices (Maudoux 
et al., 2012; Schlee, Hartmann, et al., 2009; Schmidt, Akrofi, Carpenter-Thompson, & 
Husain, 2013). It is supposed that the tinnitus reaches awareness only if there is a co-
activation between the auditory cortex and a “perception network” including parietal and 
frontal cortices (De Ridder et al., 2011). Correlations of neural processes with clinical tinnitus 
data suggest that different aspects of the tinnitus percept are encoded by separable networks 
indeed. For instance, tinnitus loudness was shown to correlate with gamma activity in the 
auditory cortex (van der Loo et al., 2009) while tinnitus distress has been linked to a general 
distress network including the anterior cingulate cortex, the DLFPC, the insula and posterior 
cingulate cortex (Vanneste, Congedo, & De Ridder, 2014; Vanneste et al., 2010). It has also 
been shown that those networks seem to be functionally interconnected in highly distressed 
patients (Vanneste et al., 2014). The current study seizes the idea of this network perspective 
with the aim of improving rTMS treatment for chronic subjective tinnitus. 
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Having the auditory pathway in mind, many clinical studies have examined the effects 
of unilateral low-frequency rTMS of the auditory cortex as a treatment for chronic tinnitus  
(for a review, see Lefaucheur et al., 2014). The results of those studies are mixed and the 
effect size is small emphasizing the need for more effective treatment protocols. One 
possibility to enhance treatment effects is to increase the number of stimulated areas. In the 
last years, this optimization strategy has also been increasingly investigated for other 
neurological or psychiatric indications for rTMS treatment like major depression or 
Parkinson’s disease. Whereas this approach revealed mixed results in depression treatment 
(Chen et al., 2014) the bilateral stimulation of the primary motor cortex has been shown to be 
superior to unilateral stimulation for the treatment of Parkinson’s disease (Lefaucheur et al., 
2014). The targeted extension of the stimulated areas might therefore represent a promising 
approach for future rTMS research and might also be useful for the treatment of chronic 
tinnitus. 
The combined stimulation of left temporal and left frontal cortices has already been 
tested in tinnitus patients. Indeed, patients receiving the combined stimulation protocol 
showed better long-term symptom improvement than patients who had been treated with 
single-site temporal stimulation (Kleinjung et al., 2008). Another study indicated that the 
combined protocol appeared in trend to be superior, but the difference was not statistically 
significant (Langguth et al., 2014). Based on these results and on the knowledge about the 
altered functional connectivity between different networks in the tinnitus brain, a new, triple-
site protocol was recently tested in a pilot, single-arm study (Lehner, Schecklmann, Poeppl, 
et al., 2013). This protocol added another target to the combined protocol of Kleinjung et al. 
(2008) resulting in three stimulation sites: bilateral low-frequency rTMS of the 
temporoparietal cortex plus high-frequency rTMS of the DLPFC. The triple-protocol targets 
the most important hubs of the tinnitus network as defined by Schlee, Hartmann et al. (2009). 
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In the pilot study, this protocol showed better long-term effects than a historical control group 
which was treated with unilateral temporal stimulation and – on a descriptive level – also 
better long-term effects than a historical control group treated with combined left temporal 
plus left DLPFC stimulation (Lehner, Schecklmann, Poeppl, et al., 2013). The current study 
intends to replicate the results of the pilot study in a randomized controlled trial. We 
determined whether the stimulation of multiple hubs of the neural networks involved in 
tinnitus is superior to the standard single-site stimulation protocol. 
 
Materials and Methods 
 Design. 
 The presented data come from a two-arm randomized, double-blind parallel-group 
trial whose design and methods were published in detail in Lehner, Schecklmann, Kreuzer et 
al. (2013, 2014). The study was registered at Clinical Trials on July 23, 2012 
(NCT01663324) and has been approved by the ethics committee of the University of 
Regensburg (10-101-0169). The study was done in accordance with the approved guidelines. 
All data were collected at the Department of Psychiatry and Psychotherapy, University of 
Regensburg between July 2012 and January 2015 (last follow-up visit). 
 
 Subjects. 
 The study was designed to find an interaction effect between group (single-site vs. 
triple-site) and time (day1, day 12). Based on our pilot data (Lehner, Schecklmann, Poeppl, et 
al., 2013) a small effect size of f = 0.1 for this interaction effect was assumed. Although 
small, such an effect is still an important step in tinnitus management. If the study sample 
size is determined to provide sufficient power (0.8) for detection of such an effect in a 
repeated measures ANOVA (with α = 0.05), a total of 42 tinnitus patients have to be 
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examined. Due to the complex and time-consuming study design, a higher patient drop-out 
rate than usual was assumed. A total of 50 patients (25 per group) aged between 18 and 70 
years were therefore enrolled in the study (see Table 10). One patient dropped out of the 
single-site stimulation group after two rTMS sessions due to an increase in tinnitus loudness. 
Due to this drop-out, data of 49 patients (35 male, 14 female, age 47.11 ± 12.13 years) are 
reported. All patients suffered from chronic subjective tinnitus with at least moderate 
handicap as measured with the THI (score ≥ 38, Newman et al., 1996). Tinnitus was present 
in all patients for at least six months. Study exclusion criteria were prior treatment with 
rTMS, clinical relevant unstable psychiatric, somatic or neurologic comorbidity and all 
standard exclusion criteria for rTMS treatment. Patients were recruited during routine clinical 
tinnitus consultations and via announcements in print-media and on the homepage of the 
tinnitus clinic at the Regensburg University. All patients gave written informed consent. 
 
 Questionnaires and outcome measures. 
 For the assessment of demographical and clinical characteristics patients completed 
the Tinnitus Sample Case History Questionnaire (Langguth et al., 2007). All questionnaires 
listed below were administered on the first treatment day (“day 1”), last treatment day 
(“day 12”) and during two follow-up visits (“day 90” and “day 180”). Tinnitus severity was 
assessed using the THI, the TQ (Goebel & Hiller, 1994) and numeric rating scales for tinnitus 
loudness and annoyance (ranging from 0 = not at all loud/annoying to 10 = extremely 
loud/annoying). Furthermore, quality of life was measured using the WHO-QoL (World 
Health Organization Quality of Life) assessment. Depressive symptoms and hyperacusis were 
assessed using the Major Depression Inventory (MDI) and a German hyperacusis 
questionnaire (Geräuschüberempfindlichkeitsfragebogen, "GÜF"; Nelting & Finlayson, 
2004). On day 1 and day 12, the hearing level [dB HL] was measured using pure-tone 
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audiometry. It is reported as an average of all thresholds measured bilaterally ranging from 
125 Hz to 8 kHz. The comparison between pre and post treatment hearing level served as 
safety parameter. The primary outcome parameters were defined as (a) the change of tinnitus 
severity from day 1 to day 12 as measured by the TQ score and (b) as the number of 
treatment responders (as defined by a reduction of at least five points in the TQ score). The 
change in the remaining questionnaires over the four measurement time points (THI, MDI, 
GÜF, WHO-QoL), the rating scales and the treatment responders on day 90 and day 180 
served as secondary outcome parameters. 
 
 rTMS treatment. 
 On the first treatment day, patients were randomized by random group allocation 
(http://www.random.org) to receive either single site or triple-site rTMS treatment. All 
patients received ten treatment sessions on ten consecutive working days. Non-blinded study 
staff assigned patients to the interventions and applied treatment. These persons were not 
involved in patient management, assessment or data analysis. The triple-site rTMS protocol 
consisted of high-frequency stimulation of the left DLPFC (20 Hz, 20 trains, 25s inter-train 
interval, 1000 pulses/day) followed by left temporoparietal and right temporoparietal 
stimulation (1 Hz, 1000 pulses/day each). The three sites were stimulated successively and 
always in the same order: DLPFC first, then left temporoparietal cortex and right 
temporoparietal cortex at the end. The single-site group was treated with 3000 pulses/day of 
the left temporoparietal cortex. Low-frequency rTMS of the left temporoparietal cortex has 
been the standard approach for rTMS tinnitus treatment during the past years(Lefaucheur et 
al., 2014). Both treatment groups received 3000 pulses per session at an intensity of 110% of 
the RMT, but – for safety reasons – never higher than 60% of the maximal stimulator output. 
The RMT was measured before the first treatment sessions and was defined as the minimal 
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intensity at which at least five of ten motor evoked potentials were 50µV in amplitude in the 
right abductor digiti minimi. Treatment was performed with a Medtronic MagPro Option 
stimulator (Medtronic, Minneapolis, MN, USA) and a 70mm figure-of-eight coil. The 
temporoparietal cortices were targeted using the 10-20 system by placing the coil between the 
temporal (T3/T4) and the parietal (P3/P4) electrode sites (Hoffman, R. E. et al., 1999; Jasper, 
1958). For targeting the DLPFC, the coil was centered 6 cm anterior from the site over the 
motor cortex that had been used for defining the RMT. 
 
 Placebo control group. 
 As the goal of the study was to test superiority of the triple-site stimulation over the 
standard approach (temporoparietal stimulation), an active stimulation protocol was chosen 
as control protocol instead of a placebo stimulation, as proposed by recent reviews (Duecker 
& Sack, 2015; Lefaucheur et al., 2014). In order to additionally offer a descriptive 
comparison to placebo stimulation, data of a placebo control group from a previous rTMS 
study (Langguth et al., 2014) is presented. Those patients were treated with a sham-coil 
system (90mm outer diameter, coil MC-B70, Medtronic, Minneapolis, MN) on ten 
consecutive working days. The coil was localized at the auditory cortex by using a PET-
guided neuronavigational system. From the 44 available placebo-datasets (Langguth et al., 
2014), 25 were chosen in order to create a group which matched the triple- and single-site 
groups with respect to the baseline TQ score, age, gender, tinnitus laterality and tinnitus 
duration (see Table 10). With respect to outcome measures, only the TQ at day 1, day 12 and 
day 90 was available. A follow-up period of 180 days is not common in previous published 
trials and is thus unique for this study. As data of this group were collected earlier by 
different study staff and under different circumstances, they will not be submitted to 
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statistical analyses. They are meant to provide a qualitative reference point for the possible 
effects of sham stimulation. 
 
 Statistical analysis. 
 For statistical analyses IBM SPSS Statistics for Windows (Version 22.0, Armonk, 
NY: IBM Corp.) was applied. Missing values were replaced by using a LOCF procedure, if at 
least one measurement after rTMS was available. Patients without post rTMS measurements 
were not included in the analysis (drop-outs). Concerning the missing values, data of four 
patients had to be replaced using LOCF on day 90 and data of two patients had to be replaced 
on day 180. As some of the questionnaires were not filled in correctly, there were some 
additional missing values for specific questionnaires. Data for two patients were missing on 
day 12 for the MDI and the GÜF questionnaires and data of one additional patient was 
missing on day 90 for the THI. On day 180, data of two additional patients were missing for 
the TQ and data for one patient were missing for the rating scales (loudness and annoyance) 
and for the MDI. In order to test whether the LOCF procedure had an effect on our results, all 
statistical tests were done twice: for the whole dataset with LOCF and for the smaller subset 
of data without LOCF. All statistical tests yielded the same results when conducted without 
LOCF replacement of missing values. 
The change of the TQ score from day 1 to day 12 (primary outcome) was tested using 
an ANOVA with the within-subjects factor measurement time point (day 1, day12) and the 
between-subjects factor group. To test for changes in tinnitus severity over all four 
measurement time points an ANOVA with the within-subjects factor measurement time point 
(day 1, day 12, day 90, day 180) and between-subjects factor group (single-site vs. triple-site 
stimulation) was calculated for all questionnaires. The prerequisites for use of ANOVAs were 
checked for all dependent variables: The homogeneity of variances was tested with Levene’s 
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Test. The result was non-significant for all variables except for the MDI on day 12. The Fmax-
Test revealed, that an adaptation of the level of significance was not necessary (Fmax = 2.04). 
The sphericity of data was checked with Mauchley Tests. In case of significant Mauchley-
Tests, Greenhouse-Geisser corrections were applied. 
Number of treatment responders on day 12 (primary outcome), day 90 and day 180 
were compared using Chi² tests. Treatment responders were defined as patients with a 
reduction in the TQ score of at least five points (Adamchic et al., 2012). For safety reasons, 
we compared the hearing level of all patients from pre to post treatment using a paired t-test 
with the within-subjects factor time (day 1, day 12). 
 
  
 
Table 10 
Demographical data and clinical characteristics for both treatment groups and the placebo control group 
 single-site rTMS (N = 24) triple-site rTMS (N = 25) placebo (N = 25) group comparisons 
age (years) 48.89 ± 10.05 45.39 ± 13.83 52.80 ±13.32 F(2,71) = 2.18; p  = .12 
gender 17 m, 7 f 18 m, 7 f 18 m, 7 f χ2(2,74) =.01; p > .99 
mean hearing threshold [dB HL] 33.79 ± 13.48 27.71 ± 10.46  t(47) = 1.77; p = .083 
tinnitus laterality 
(r/l/l>r/r>l/both/inside head) 
2/5/4/4/8/1 5/6/3/5/5/1 3/6/4/3/7/2 p =.98 
(Fisher’s Exact Test) 
duration (months) 120.14 ± 118.02 103.93 ± 118.78 95.64 ± 85.46 F(2,71) = 0.32; p = .73 
Questionnaire scores on day 1 
TQ 44.42 ± 16.66 45.56 ± 13.75 45.24 ± 15.90 F(2,71) = 0.04; p = .97 
THI 50.17 ± 22.26 47.36 ± 17.94  t(47) = 0.49; p = .63 
MDI 6.25 ± 3.97 7.68 ± 5.60  t(47) = -1.03; p = .31 
GÜF (n = 47) 15.70 ± 8.40 16.54 ± 9.34  t(45) = -0.33; p = .75 
WHO-QoL Domain 1 16.23 ± 2.50 15.31 ± 2.38  t(47) = 1.32; p = .19 
WHO-QoL Domain 2 15.29 ± 2.19 14.13 ± 2.56  t(47) = 1.70; p = .096 
WHO-QoL Domain 3 16.21 ± 2.41 15.15 ± 2.95  t(47) = 1.38; p = .18 
WHO-QoL Domain 4 17.08 ± 1.54 16.45 ± 2.09  t(47) = 1.18; p = .24 
Note. Mean hearing threshold (in dB HL): average of all thresholds measured bilaterally ranging from 125 Hz to 8 kHz; Tinnitus laterality is 
defined in categories: r: right-sided, l: left-sided, l>r: both sides but louder on the left side; r>l: both sides but louder on the right side; both: both 
sides; inside head: Tinnitus is perceived in the middle of/ inside the head; TQ: Tinnitus Questionnaire; THI: Tinnitus Handicap Inventory; MDI: 
Major Depression Inventory; GÜF: Geräuschüberempfindlichkeitsfragebogen (German Hyperacusis Questionnaire); WHO-QoL: World Health 
Organization-Quality of Life. 
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Results 
 Adverse events. 
 Both the left temporoparietal and the triple-site stimulation protocol were well 
tolerated by the patients. No serious adverse effects were observed. There was no significant 
change of the hearing level from pre to post rTMS treatment (t(48) = -1.38, p = .17). The 
adverse events for both treatment groups are listed in Table 11. 
 
 Statistical analysis. 
 Concerning the primary outcome (change in the TQ score from day 1 to day 12), the 
effect of measurement time point was significant (F(1,47) = 23.97, p < .001) with the TQ 
score decreasing from 45.00 (± 15.10) to 40.41 (± 15.61). The effect of group was not 
significant (F(1, 47) = 0.06, p = .80) and there was no significant interaction effect between 
measurement time point and group for the change in the TQ score from day 1 to day 12 
(F(1, 47) = 0.003, p = .96). Furthermore, there was no significant difference between groups 
in the responder rates on day 12 (10 responders in each group, χ2(1, N = 49) = 0.01, p = .91). 
Concerning the secondary outcome measures (ANOVAs comparing all four measurement 
time points for all questionnaires) significant effects of measurement time point were 
observed for the TQ (see Figure 6), the THI and the rating scale “annoyance” (see Table 12). 
The measurement time point effect for the rating scale “loudness” was marginally significant. 
For the TQ, post-hoc t-tests revealed significant differences from day 1 to day 12 
(t(48) = 4.94, p < .001), from day 1 to day 90 (t(48) = 2.26; p = .029) and to day 180 
(t(48) = 2.67, p = .010). The same differences were significant for the THI (day 1 to day 12: 
t(48) = 3.13, p = .003; day 1 to day 90: t(48) = 3.00, p = .004; day 1 to day 180: t(48) = 2.89, 
p = .006) and the rating scale “annoyance” (day 1 to day 12: t(48) = 2.11, p = .040; to day 90 
t(48) = 2.40, p = .20; to day 180: t(48) = 2.31, p = .025). No significant effects of group were 
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observed (see Table 12). The interaction effects measurement time point x group were not 
significant either. There was no significant difference between groups in the responder rates 
on day 90 (9 responders in the single-site group, 13 responders in the triple-site group, 
χ2(1, N = 49) = 1.04, p = .31) or on day 180 (10 responders in the single-site group, 14 
responders in the triple-site group, χ2(1, N = 49) = 1.01, p = .32). 
 
 Descriptive comparison with the placebo control group. 
 In Figure 6, the change of the TQ score from day 1 to all subsequent measurement 
time points is shown for all three groups separately with negative values indicating a 
reduction of tinnitus severity. For the placebo group, only data for day 12 and day 90 were 
available. On a descriptive level, both study groups show more reduction of the TQ score 
than the placebo group on day 12. On day 90, the triple-site group shows the most 
pronounced reduction of the TQ, followed by the single-site group. Please note that the group 
x measurement time point interaction effect was not significant for the two treatment groups. 
For the placebo group nearly no change of the TQ score was visible on day 90. 
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Table 11 
Adverse events for both treatment groups 
 single-site rTMS triple-site rTMS 
transient adverse events - - 
muscular tension 1 - 
headache 6 3 
blurred vision 1 - 
increase in tinnitus loudness 3 - 
mood swings 1 - 
dizziness - 1 
feeling of heaviness in the legs - 1 
ongoing adverse events - - 
increase in tinnitus loudness 3* - 
broadening of the frequency range of the 
tinnitus 
- 1 
Note. * One of those three patients dropped out after two days of treatment. 
 
   
  
 
Table 12 
Results from repeated measures analyses of variance 
 
main effect: measurement time point  main effect: group  
interaction effect: measurement time 
point x group 
 F (df) p Eta
2
  F (df) p Eta
2
  F (df) p Eta
2
 
TQ F(2.23, 104.96) = 4.94 .007* 0.094 F(1, 47) = 0.003 .95 >0.001 F(2.23, 104.96) = 0.66 .54 0.013 
THI F(2.48, 116.33) =5.02 .005* 0.095 F(1, 47) = 0.55 .46 0.012 F(2.48, 116.33) =1.09 .35 0.021 
MDI F(2.49, 116.83) = 0.92 .43 0.019 F(1, 47) = 0.46 .50 0.10 F(2.49, 116.83) = 1.14 .33 0.023 
GÜF F(2.34, 105.26) = 1.99 .13 0.041 F(1, 45) = 0.004 .95 > 0.001 F(2.34, 105.26) = 1.33 .27 0.027 
loudness F(2.20, 103.58) = 2.38 .092
#
 0.048 F(1, 47) = 0.02 .89 >.001 F(2.20, 103.58) = 0.39 .70 0.008 
annoyance F(2.50, 117.28) = 3.17 .035* 0.063 F(1, 47) = 0.52 .48 0.011 F(2.50, 117.28) = 0.40 .72 0.008 
WHO-QoL 
domain 1 F(3, 141) = 0.78 .51 0.016 F(1, 47) = 0.94 .34 0.020 F(3, 141) = 0.70 .56 0.014 
domain 2 F(2.48, 116.66) = 0.16 .89 0.003 F(1, 47) = 1.15 .29 0.024 F(2.48, 116.66) = 1.78 .17 0.036 
domain 3 F(2.28, 107.21) = 0.63 .60 0.013 F(1, 47) = 2.33 .13 0.047 F(2.28, 107.21) = 0.14 .89 0.003 
domain 4 F(2.58, 121.37) = 0.65 .58 0.013 F(1, 47) = 1.24 .27 0.026 F(2.58, 121.37) = 0.40 .59 0.012 
Note. *α ≤.05; # α < .10.
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Figure 6. Reduction in the TQ sum score from day 1 to all subsequent measurement time 
points (for the placebo group only data for day 12 and day 90 were available). Error bars 
represent standard errors. 
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Discussion 
 Recent studies have suggested that alterations of the connectivity between and within 
widespread neural networks including frontal, parietal and temporal areas are associated with 
chronic tinnitus (De Ridder et al., 2011, 2014; Schlee, Hartmann, et al., 2009; Vanneste et al., 
2014). The current study aimed to use this knowledge about tinnitus pathophysiology for a 
new treatment option by stimulating three central hubs of these neural networks involved in 
tinnitus. Results indicate that both the single-site and the triple-site protocols led to a 
significant reduction of tinnitus severity which emphasizes the potential of rTMS for the 
treatment of tinnitus. However, the superiority of the triple-site protocol was modest at best 
(Figure 6) and the effect sizes were small (see Table 12). At first glance these results do not 
agree with an earlier study from our group (Lehner, Schecklmann, Poeppl, et al., 2013). On a 
descriptive level however, the present results resemble those of the pilot study and a 
superiority of the triple-site stimulation can be observed 90 days (see Figure 6) and in trend 
180 days after rTMS. The single-site group reported a reduction in tinnitus severity on day 
90. This matches exactly what was observed in the pilot study. One possible reason for the 
lack of statistical significance of the current results in comparison to the pilot data might be 
that data of the pilot study were not matched with respect to the number of applied pulses. In 
the pilot study the triple-site group received 4000 pulses per session, the single-site group 
received only 2000 rTMS pulses per session. There is evidence that treatment with more 
pulses results in a more pronounced effect both for the treatment of depression (Gershon, 
Dannon, & Grunhaus, 2003) and the treatment of tinnitus (Plewnia et al., 2007). Therefore, 
the higher dose of the triple-site stimulation might have contributed to its superiority in the 
pilot study. As the number of pulses was kept constant in the current study design, this 
lacking dose-effect might be one reason for the unexpected non-significant outcome. This 
makes clear that future studies investigating multisite stimulation should take the number of 
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pulses into account. If multi-site stimulation involves a higher number of pulses, a possible 
superiority of multi-site stimulation could be simply the consequence of a higher dose. 
Moreover the relative small sample sizes of our study for detecting a differential 
effect of two active protocols has to be considered in the interpretation of data. The observed 
effect size of Eta
2
 = 0.013 for the interaction effect between measurement time point and 
group concerning the TQ is small but might still be in a range of clinical relevance. Although 
tiny, this effect suggests that there might be some advantage of multisite protocols to evoke a 
more sustained reduction of tinnitus severity. 
The tendency towards a better, albeit modest, long-term effect of the triple-site 
protocol, which was observed in the current study, is in line with other studies that 
administered combined treatment protocols (Kleinjung et al., 2008; Kreuzer et al., 2011) and 
indicates the potential of the concept to stimulate multiple sites of a pathologically altered 
brain network. The idea of stimulating several hubs of the neural networks involved in 
tinnitus can and should encourage new concepts of multisite-treatment protocols. There are 
diverse variables which can be varied in future protocols: How many areas should be 
stimulated in which frequency and in which order? We chose to stimulate all patients in the 
triple-site group with the same stimulation sequence (first DLPFC, then left and right 
temporoparietal cortex) in order to stick to the protocol of the pilot study (Lehner, 
Schecklmann, Poeppl, et al., 2013) and in order to be able to use a sample size small enough 
to enable us to also include EEG and fMRI measurements (Lehner, Schecklmann, Kreuzer, et 
al., 2013). Future studies could randomize the order of the stimulated sites in order do find 
out which sequence of stimulated areas might be most effective. Moreover, it might be more 
effective if stimulation sites were not treated successively but simultaneously or with a 
particular timing between the magnetic pulses over different stimulation sites. More 
knowledge about tinnitus pathophysiology is needed to define treatment protocols which are 
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able to effectively interfere with the tinnitus-specific alterations. Recent studies already 
provide important information for potential future treatment protocols by presenting 
increasingly refined knowledge about the neural networks involved in the tinnitus percept. 
While the current study was motivated by the finding of frequency-specific changes of 
functional connectivity between temporal, parietal, frontal and cingulate cortices in tinnitus 
patients (Schlee, Hartmann, et al., 2009), more recent studies define separate distress and 
loudness networks with e.g. increased electroencephalographic alpha activity in prefrontal 
areas and increased beta activity in the dorsal anterior cingulate cortex (Vanneste et al., 
2014). However, the results of such studies are still mixed with respect to the network hubs 
considered to be important and the frequencies with which alterations of connectivity can be 
perceived. Combining treatment studies with brain imaging can help to specify in more detail 
which changes of functional connectivity are correlated with treatment response and should 
therefore be targeted (Langguth et al., 2012). Another promising approach to improve (multi-
site) rTMS treatment is customizing brain stimulation to each patient. As tinnitus is a 
heterogeneous condition the information which neural networks are altered in the tinnitus 
brain in general may be less relevant than the alterations which are present in the individual 
tinnitus patient at the very moment we intend to apply rTMS treatment. It is well-known that 
the effect of rTMS is dependent on the status of the brain at the time the stimulus is applied 
(Siebner et al., 2009). It might be therefore a promising task for future studies to identify the 
optimal treatment protocol for each patient and eventually also for each treatment session 
separately. A further approach to improve rTMS treatment might be related to increases of 
the dosage of rTMS. This can be done either by increasing the applied pulses per day or the 
number of treated days. Here, we stimulated with 3000 pulses per day showing remarkable 
changes in tinnitus distress which were higher in comparison to a recent meta-analysis 
(Soleimani et al., 2015) and a retrospective analysis of over 500 patients (Lehner et al., 2012), 
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where a lower number of pulses per day was used (Soleimani et al., 2015). A higher number 
of treatment sessions is common in the rTMS treatment of patients suffering from major 
depression. In these patients, rTMS treatment for four to eight weeks (George & Post, 2011; 
George, Taylor, & Short, 2013) has been approved by the Food and Drug Administration in 
the United States and may also represent a promising approach in improving treatment effects 
in patients with tinnitus. 
 
Conclusions 
 We report a tendency towards a modest, sustained long-term effect of the triple-site 
stimulation protocol in comparison to the single-site protocol. This descriptive advantage 
shows that innovative treatment protocols carry potential for a more effective treatment of 
subjective tinnitus. Future work could aspire to apply novel protocols based on emerging 
knowledge about tinnitus pathophysiology and, above all, about the individual tinnitus brain. 
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Concluding Discussion 
Methodical considerations 
 Study design. 
 Study 1 was not an experimental study but a pooled, retrospective analysis of 
longitudinal imaging data of tinnitus patients who underwent MRI before and after the 
treatment phase of 10 sessions of rTMS. Up to now, this is the only study that examined the 
effect of rTMS treatment with respect to GM changes in tinnitus patients. Due to its 
longitudinal character, every patient acted as his own control which is strongly recommended 
for studies measuring brain volume (Steen, Hamer, & Lieberman, 2007). The main limitation 
of the study design used is the lack of a placebo-control group. It has already been addressed 
in the discussion of study 1 that this limitation considerably restricts the interpretation of the 
results as it cannot be excluded that the perceived GM changes were due to unspecific effects 
independent of rTMS treatment. Furthermore, the correlation of TQ difference with the 
baseline GM volume in the lingual gyrus and parts of the frontal gyrus might also be 
independent of rTMS effects. Maybe, GM volume in these structures is not a predictor for 
rTMS outcome but a predictor for an improvement of tinnitus severity independent of any 
intervention. A special characteristic of study 1, which should also be mentioned, is that data 
coming from different clinical trials were pooled. The main reason for using pooled data was, 
that the effects of low-frequency rTMS are known to be rather small (Meng et al., 2011) and 
hence the GM changes were also expected to be small. Therefore, a large sample size was 
considered to be of particular importance for the current study. Being able to present data of a 
large sample of 77 patients some of which were scanned three times was only possible by 
aggregating data of different trials. Although this kind of analysis does not meet the high 
standard of a randomized controlled trial, the pooling of imaging data is considered an 
important next step in neuroimaging research (Poline et al., 2012). Large neuroimaging 
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databases have been formed within the last years e.g. for schizophrenia research (Wang et al., 
2016) or for Alzheimer disease (Neu, Crawford, & Toga, 2016). Indeed, an international 
workgroup of researchers has been formed (COST TINNET Workgroup 3; 
http://tinnet.tinnitusresearch.net/index.php/2015-10-29-10-22-16/wg-3-neuroimaging) that is 
trying to establish an international database for imaging data of tinnitus patients as well. 
Therefore, pooled analyses can be considered an acceptable and important way to collect 
imaging data now and in the future. Moreover, there is longitudinal imaging data waiting to 
be analysed which was collected in the course of study 3. These data were collected in the 
course of a randomized controlled trial and is eligible to replicate the results of the pooled 
analysis of study 1. 
Study 2 was a one-arm open-label study in which the triple-site treatment protocol 
was explored for the very first time. The study focused on the question whether the new 
protocol was safe, feasible in the clinical routine and tolerable. This pilot study was done in 
order to find out if the protocol should be investigated in a more elaborate controlled trial or 
if the concept of triple-site stimulation should be rejected. As Landgrebe et al. stated “only 
‘promising’ interventions justify the performance of a RCT [randomized controlled trial]. The 
choice of a promising intervention is difficult and can be based on clinical pilot data (…)” 
(Landgrebe et al., 2012, p. 5). In order to provide a rough estimate of the new stimulation 
protocol’s effectiveness, the pilot data were compared to data of a control group from a 
previous trial which was stimulated with the standard low-frequency stimulation protocol. 
This approach entailed some confounding factors which have already been addressed in the 
discussion of study 2 but should again be mentioned for the sake of completeness: First, the 
number of TMS pulses was not kept constant in this pilot study. While the control group was 
treated with 2000 pulses per session, the triple-site group received 4000 pulses per session. 
As the effect of rTMS is known to be dose-dependent (Plewnia et al., 2007), it is important to 
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apply the identical number of pulses in cases where two treatment protocols are compared. 
Furthermore, many patients in study 2 were medicated with centrally acting drugs which – 
even if held constant during the rTMS treatment phase – might have influenced the rTMS 
treatment effect. The conclusions drawn from study 2 should therefore be considered 
preliminary as systematic biases cannot be excluded. 
As study 3 was done in order to replicate the results of study 2, particular attention 
was paid to those limitations. Study 3 was designed as two-arm parallel-group trial with 
randomized group allocation. Both treatment groups received the same number of pulses per 
session. Furthermore, patients could only be included if they were not taking centrally acting 
drugs. Still, this study does not meet the gold standard of a randomized, placebo-controlled 
trial as no placebo control group was chosen. As has already been addressed in the discussion 
of study 3, this was done because the intention of the trial was to find out whether the triple-
site protocol was superior to the standard protocol used in tinnitus treatment (Lehner, 
Schecklmann, Kreuzer, et al., 2013, 2014). It is indisputable, of course, that placebo-
controlled trials are clearly needed to control for non-specific effects such as patient 
expectation or spontaneous improvement (Landgrebe et al., 2012). However, a placebo 
condition complicates patient recruitment, especially if rTMS is provided as outpatient 
treatment. This is the reason why placebo-controlled trials often require large and expensive 
multi-center studies in order to be able to obtain sufficiently large patient samples (e.g. 
Landgrebe et al., 2008). Considering that there are countless possibilities of how rTMS 
treatment effects might be enhanced (see discussion below) and that many possible protocols 
wait to be tested, it becomes clear that small, less costly trials are necessary in order to find 
out which treatment protocols are promising enough to initiate an expensive placebo-
controlled trial. 
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Another disadvantage of an actively controlled trial is that it is more difficult to find a 
significant difference to a treatment group than to a placebo group. However, if the goal of a 
study is to improve rTMS treatment, the new treatment protocol should be superior to the 
already existing standard stimulation protocol and therefore this standard protocol should be 
chosen as control condition. Although conservative, this is what was done in study 3. A final 
shortcoming of the control group is that the triple- and single-site protocols differed in more 
than one parameter. While the number of pulses was kept constant, the number of stimulation 
targets and the frequency of stimulation were (partly) different. Therefore, all those 
parameters could have contributed to the tendency of a better long-term effect of the triple-
site stimulation protocol. In order to disentangle those effects a step-wise approach would be 
necessary in which only one parameter is changed at a time.  
 
 Study samples. 
 As tinnitus is a very heterogeneous condition with respect to its causes, clinical 
characteristics (Langguth, Kleinjung, & Landgrebe, 2011) and comorbid symptoms such as 
depression, anxiety (Langguth, Landgrebe, Kleinjung, Strutz, & Hajak, 2010), sleep 
disturbances (Schecklmann et al., 2015) or hyperacusis (Schecklmann et al., 2014), a 
thorough clinical diagnosis of the individual patient is necessary to ensure optimal care. It has 
to be determined whether the patient’s tinnitus is objective or subjective, whether it has a 
pulsatile character and whether there are causes which might benefit from special treatment 
options like hearing aids, cochlear implants or microvascular decompression (Langguth et al., 
2013). All patients treated in the course of this thesis underwent an in-depth diagnostic 
procedure including audiological measurements, examination by an otorhinolaryngologist, 
psychiatrist and other specialists if necessary. Only if tinnitus was subjective and if no clear 
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indication for a specialized treatment was present, patients were possible candidates for 
treatment with rTMS. 
Recruitment and rTMS treatment of all patients was done in a multidisciplinary 
tinnitus centre offering outpatient care. Usually, patients have to wait several months for their 
first appointment in the clinic and in many cases those patients have already undergone many 
different treatment attempts before consulting the tinnitus clinic. Therefore, patient selection 
is clearly biased towards patients who have had their tinnitus for a very long time, who feel 
highly distressed and who have shown to be treatment-resistant to many other treatment 
attempts. Therefore, the current results may not generalize to other patient populations. 
 
 Outcome measurement. 
 In order to be able to define treatment outcomes in clinical trials, valid metric 
variables are needed which are sensitive to change. The term “subjective tinnitus” implies 
that there is no objective measurement of the phantom sound. Every assessment is dependent 
on the patient’s ability to verbally describe his or her tinnitus and to perceive whether it has 
changed during a therapeutic intervention. Therefore, there is an ongoing debate about 
optimal outcome measures for clinical trials in tinnitus. There are several characteristics 
which can be measured (e.g. tinnitus distress, loudness, minimal masking level) and also 
different possibilities of how these characteristics can be measured (e.g. using different 
questionnaires). Recently, an international initiative was founded in order to define an 
international standard of outcome measurement (Hall et al., 2015). For the current thesis, two 
outcome measures were chosen which were used in each of the three studies reported and 
therefore providing comparability between the presented results: tinnitus distress and tinnitus 
loudness. Tinnitus distress was quantified using the German version of the TQ (Goebel & 
Hiller, 1994; Hallam et al., 1988). As the internal consistency of the TQ is very high (r = 94) 
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and the questionnaire is supposed to be sensitive to change, it was chosen as the primary 
outcome measure in all three studies. The TQ comprises 52 items. The sum score ranges from 
zero to 84 and can be used to assess tinnitus severity with higher scores indicating more 
pronounced tinnitus severity. Changes of at least five points in the TQ are thought to be of 
clinical relevance (Adamchic et al., 2012). Therefore, patients were defined as treatment 
responders in all three presented studies if they had improved at least five points in the TQ. 
The subjective loudness of the tinnitus was also measured in each of the studies using a rating 
scale (“How strong or loud is tinnitus at present?”) ranging from 0 (“not at all”) to 10 
(“extremely strong or loud”). 
 Depending on the aim of the three studies, some additional outcome parameters were 
used. As study 2 was a pilot study, four additional rating scales were measured in order to 
cover extra dimensions of tinnitus which might reflect treatment response to the innovative 
treatment protocol. All of those rating scales seemed to measure the same trend in study 2 
(please see Figure 4). Therefore, only tinnitus loudness was reported in study 3. 
 In addition to the TQ, the German version of the THI was additionally used to 
measure tinnitus severity in both study 2 and 3 (Kleinjung, Fischer, et al., 2007; Newman et 
al., 1996). The THI is an internationally and widely used questionnaire for tinnitus distress 
and thus enables the results to be put in context of worldwide clinical trials. This was 
considered to be of particular importance for a newly developed treatment protocol like the 
triple-site protocol. The THI is comprised of 25 items. The sum score ranges from zero to 
100, again with higher scores indicating more tinnitus distress. 
 Finally, a quality of life assessment was added as outcome measure to study 3 as we 
hypothesized that an improvement of tinnitus should be reflected in patients’ daily lives. As a 
reliable, valid and open-access questionnaire, the WHO-QoL was considered to be suitable 
for quantifying this supposed change in quality of life (O'Carroll, Smith, Couston, Cossar, & 
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Hayes, 2000; Skevington, Lotfy, & O'Connell, 2004). The WHO-QoL measures four 
domains of quality of life: physical health, psychological health, social relationships and 
environment. As no changes in any of those domains were seen in study 3, it can be supposed 
that treatment effects appear to have been too weak to induce measurable quality of life 
changes. 
 
 Hearing loss as confounding factor. 
 With hearing loss being probably the most important risk factor for tinnitus (Axelsson 
& Ringdahl, 1989) it is a very important confounding factor in tinnitus research. Hearing loss 
itself is supposed to lead to e.g. plastic changes and hyperactivity in the central auditory 
pathway (Salvi, Wang, & Ding, 2000; Zhao, Song, Li, & Li, 2016). It is therefore a challenge 
to disentangle hearing loss- and tinnitus-related effects when trying to understand tinnitus 
pathophysiology. Consequently, one important limitation of study 1 is that the mean hearing 
threshold could not be included in the GM analyses as it was not available for all patients. 
 Differential GM changes due to hearing loss and tinnitus have indeed been described 
(Husain et al., 2011). As study 1 was a longitudinal study in which every patient acted as his 
own control, it can be supposed that the hearing threshold was most probably stable for the 
period of 10 days (from before to after rTMS treatment). Therefore, hearing loss should have 
had no influence on GM changes. Furthermore, hearing loss does not seem to be correlated 
with treatment response (Lehner et al., 2012). Nonetheless, it cannot be excluded that hearing 
loss may represent a confounding factor for GM changes due to rTMS. In the course of study 
3, all patients underwent both pure tone audiometry and magnetic resonance imaging 
(Lehner, Schecklmann, Kreuzer, et al., 2013). The imaging data have not been analysed yet 
but will be helpful in the process of disentangling rTMS induced GM changes in patients 
with and without hearing loss. 
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rTMS as a treatment tool for chronic subjective tinnitus 
 Summary: contribution of the current thesis to tinnitus research. 
 rTMS treatment protocols consist of many parameters all of which can be changed in 
order to enhance treatment effects: coil localization, frequency, stimulation intensity, number 
of pulses, number of treatment sessions and a countless amount of possible combinations of 
multiple stimulation targets with variable stimulation order. In the current thesis, two 
different approaches have been used to optimize rTMS treatment effects in tinnitus patients. 
 The goal of study 1 (Lehner, Langguth, et al., 2014) was to gain more knowledge 
concerning structural brain changes underlying rTMS treatment effects and to identify 
potential predictors for treatment outcome. With respect to the first question, no correlations 
between GM changes and changes in tinnitus severity were observed. With respect to the 
second question it was shown, however, that GM volume might be useful as a predictor for 
treatment outcome. This result is of particular interest as before study 1, we conducted 
another analysis in which we tried vainly to identify demographical or clinical characteristics 
which were able to predict treatment outcome (Lehner et al., 2012). Therefore, neural 
predictors such as GM volume are clearly needed. In study 2 (Lehner, Schecklmann, Poeppl, 
et al., 2013) and study 3 (Lehner, Schecklmann, Greenlee, Rupprecht, & Langguth, 2016), an 
innovative triple-site stimulation protocol was examined for the very first time in order to 
find out whether this protocol was safe and feasible and whether it was superior to the 
standard single-site stimulation protocol. While a superiority of the new protocol was 
indicated in the pilot study (study 2), this result could not be replicated on a statistically 
significant level in a randomized controlled trial (study 3). However, on a descriptive level, a 
better long-term effect of the triple-site protocol was observed. These results indicate that a 
higher number of stimulation targets alone may not to be sufficient to significantly disrupt the 
altered neural networks involved in tinnitus and to enhance long-term treatment effects. In the 
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following paragraphs, these results are discussed in a broader scientific context and 
implications for future research will be made. 
 
 Study 1: VBM to measure and predict rTMS treatment effects. 
 The results of study 1 indicate that changes of GM volume do not correlate with 
changes in tinnitus severity induced by rTMS treatment. Therefore, it was concluded that 
VBM might not be sensitive enough to detect neural mechanisms which are related to 
treatment response (Lehner, Langguth, et al., 2014). A region of interest (ROI) approach 
instead of whole brain analyses might have yielded more promising results. A study by 
Furtado et al. (2013) investigated the relation of brain volume and rTMS treatment effects in 
patients suffering from major depression using a ROI approach. This study reported an 
association between the antidepressant response and volume changes of amygdala and 
hippocampus. However, the antidepressant effects in that study were larger than the effects 
on tinnitus severity observed in study 1 and the correlation with amygdala volume was 
reported to be only near significant (Furtado et al., 2013). Most likely, larger treatment effects 
are necessary in order to be represented by GM volume changes which are large enough to be 
measurable using VBM. Therefore, the rTMS effects on tinnitus severity might still be too 
small to induce detectable GM changes. 
 When it comes to the question whether pre-treatment GM volume may be a predictor 
for treatment response, the results of study 1 are more promising with GM volume in the 
frontal cortex and the lingual gyrus being correlated with treatment outcome. Although this is 
the only study addressing this question in tinnitus patients so far, very recent studies in post-
stroke patients and patients suffering from auditory hallucinations have also reported 
relations between brain volume at baseline and treatment outcome. It was shown, for 
example, that white matter volume in the cortical region just below the TMS coil predicted 
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the response to a motor learning task in post-stroke patients (Brodie, Borich, & Boyd, 2014) 
and that in responders to rTMS treatment, there was better pre-treatment volume preservation 
of parts of the internal capsule (Carey et al., 2014). Nathou et al. (2015) found that GM 
density and scalp-to-cortex distance in the area below the TMS coil and also in the primary 
hand motor cortex were predictors for treatment effects in patients suffering from auditory 
hallucinations. Consequently, it might be promising for future studies to investigate GM 
volume in general and GM volume of the region below the TMS-coil in particular as 
potential predictor for treatment outcome using ROI analyses. The longitudinal imaging data 
which was collected in the course of study 3 (Lehner, Schecklmann, Kreuzer, et al., 2013) is 
waiting to be analysed. In these data, different TMS targets were used. ROI analyses of the 
baseline GM volumes in the target areas will be able to add knowledge concerning this issue. 
 
 Study 2 and 3: reasons for high inter-individual variability. 
 The high inter-individual variability of rTMS effects which have been observed in 
tinnitus patients (Lefaucheur et al., 2014) have also been reported in other contexts (Dayan et 
al., 2013) and are most likely due to the complex mechanisms in the brain that underlie rTMS 
treatment effects. As has already been mentioned in the introduction, TMS is state-dependent: 
A magnetic pulse is assumed to have a differential effect on the cortex depending on its 
activational state (Dayan et al., 2013; Siebner et al., 2009). Although high-frequency rTMS 
has been reported to exert excitatory effects and low-frequency rTMS to induce inhibitory 
effects (Dayan et al., 2013), it is debatable, whether this classification does accurately reflect 
reality and whether these effects which were observed stimulating the motor cortex can be 
generalized to other cortical areas. As far as the temporal cortex is concerned, there is 
evidence that a more complex interaction between the activational state of the stimulated area 
and the frequency of TMS pulses has to be considered to explain rTMS effects (Weisz et al., 
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2012). Furthermore, morphological differences such as the scalp-to-cortex distance have been 
shown to affect the resultant stimulation intensity that reaches the cortex (Stokes et al., 2005). 
Hence, even in healthy humans, there are numerous variables which have an impact on a 
TMS pulse’s effect on the brain and which contribute to the variable outcome which the 
apparently same rTMS protocol produces in different individuals.  
 In contrast to the healthy brain, there are even more variables which may alter the 
effect of TMS pulses in tinnitus patients. Tinnitus is a heterogeneous symptom with multiple 
possible causes and diverse clinical characteristics (Langguth et al., 2013) all of which might 
have a differential effect on brain structure and function. This heterogeneity of tinnitus 
patients may be also reflected by the heterogeneous treatment outcome. Patients with a 
specific type of tinnitus might respond to rTMS in general or to triple-site rTMS in particular 
while others do not. To date, there are no clinical, demographical (Lehner et al., 2012) or 
even neural predictors for rTMS outcome. Thus, no tinnitus-specific inclusion or exclusion 
criteria were available for the studies presented in this thesis. Tinnitus patients with diverse 
tinnitus characteristics were included. It is therefore not surprising that the triple-site protocol 
suffers from the same high inter-individual variability of treatment effects which has already 
been observed in former studies. The clinical relevant change of five points in the TQ sum 
score (Adamchic et al., 2012) was only reached in 50% (study 2) and 56% (study 3) of 
patients if measured after the follow-up period of 90 days. Albeit innovative, the triple 
network-stimulation might only be effective for certain tinnitus patients whereas others might 
have benefited from slightly different stimulation parameters. 
 
 Future directions to optimize rTMS treatment. 
 Besides finding predictors for treatment outcome or examining innovative treatment 
protocols, there are some additional possible parameters in rTMS treatment which can be 
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varied in order to improve treatment effects – some of which might be very promising and are 
therefore worth mentioning. One parameter which has rarely been investigated is the number 
of treatment courses. Usually, rTMS treatment consists of five to ten treatment sessions 
(Lefaucheur et al., 2014) and then stops. In parallel to study 3, we analysed data of patients 
who underwent at least two rTMS treatment courses in order to find out whether a repetition 
of rTMS treatment might help to maintain or even enhance treatment effects (Lehner, et al., 
2015). The results revealed that both the first and the second treatment course resulted in a 
significant improvement of tinnitus severity especially in patients who worsened in between 
the two treatment courses. Therefore, the repetition of rTMS might be a good tool to maintain 
treatment effects. 
 Furthermore, a higher number of sessions per treatment course might also be 
promising to enhance treatment effects. In patients suffering from major depression, 15 to 20 
sessions per rTMS treatment are common practice and quite effective as “the efficacy of HF 
[high-frequency] rTMS of the left DLPFC in depression is definite” (Lefaucheur et al., 2014, 
p. 2178). It would therefore be a reasoned next step to schedule more than 10 sessions in the 
treatment of tinnitus patients as well – especially because of the known dose-dependency of 
rTMS in tinnitus patients (Plewnia et al., 2007). In order to investigate whether more 
treatment sessions lead to better treatment success, we are currently collecting data for a 
study which compares the effects of 10 versus 20 treatment sessions. 
 While in past studies, it was mostly the impact of parameters such as frequency or 
stimulation target which was investigated (e.g. Khedr et al., 2008, 2010), a different type of 
coil might also help to optimize treatment effects. For all studies of the current thesis, the 
standard figure-of-eight coil was used. Recently, a new coil, the “double cone coil” was 
invented which is said to have an expanded stimulation depth and is therefore able to 
stimulate deeper cortical areas (Hayward et al., 2007). As deeper brain structures such as the 
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anterior cingulate cortex have been shown to be involved in tinnitus distress (Vanneste et al., 
2010), this new coil might turn out to be a precious tool in tinnitus treatment. To date, studies 
using this coil for the treatment of tinnitus are rare and results are mixed. Just as for the 
figure-of-eight coil, the effects of the double-cone-coil on either the parietal (Vanneste, van 
der Loo, Plazier, & De Ridder, 2012) or the frontal cortex (Vanneste, Plazier, Van de 
Heyning, & De Ridder, 2011) seem to be dependent of stimulation frequency and number of 
sessions (Vanneste & De Ridder, 2013). In parallel to study 3, we collected data to compare 
the effect of two combined treatment protocols: left temporoparietal stimulation plus either 
left DLPFC stimulation with the standard figure-of-eight coil or medial frontal stimulation 
with the new double-cone-coil (Kreuzer et al., 2015). In this study, no superiority of 
stimulation with the new coil was observed. It will be a challenge for future research to find 
the optimal stimulation target and frequency for the double-cone-coil in order to benefit from 
its ability to reach deeper brain structures. 
 Of course, an optimization of stimulation protocols does still hold much potential to 
enhance treatment effects. To this end, more refined knowledge about the pathophysiology of 
tinnitus will be mandatory. The design of the triple-site treatment protocol was based on the 
concept of a tinnitus network as proposed by Schlee, Hartmann et al. (2009). Although the 
idea that tinnitus is the result of activity in, and connectivity between, multiple cortical 
networks might still hold true, the different networks might not be of equal importance in 
different tinnitus patients. For future “network stimulation protocols” it will be of relevance 
to find out, whether other network hubs than those in the triple-site protocol should be 
targeted to interrupt the altered (network) activity. For instance, besides the already described 
subnetworks which may contribute to tinnitus generation and maintenance (De Ridder et al., 
2011), recent findings concerning the chronification of pain might provide an important hint 
for future treatment protocols. It has been shown that an initially greater functional 
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connectivity between the prefrontal cortex and the nucleus accumbens predicts whether pain 
persisted or recovered (Baliki et al., 2012). As tinnitus and chronic pain are known to be 
similar (De Ridder et al., 2011; Moller, 1997), those mechanisms might also play a role in 
tinnitus. If this is the case, treatment protocols targeting the limbic system could help to 
prevent the chronification of the phantom sound. The observed tendency towards a better 
long-term effect of the triple-site protocol could also be explained by this limbic involvement. 
High-frequency stimulation of the DLPFC has been shown to induce activity changes in the 
basal ganglia (Speer et al., 2000) which might have led to longer lasting treatment effects if 
the circuitry involved in the chronification of tinnitus was manipulated. This is mere 
speculation though and further studies are needed to find out whether a more directed 
stimulation of the basal ganglia (e.g. by using the double-cone-coil) leads to better treatment 
effects and whether the corticostriatal connectivity plays a role in the chronification of 
tinnitus at all. 
Another approach to optimize simulation protocols might be the simultaneous rather 
than the successive stimulation of different network hubs. Recently, a multi-channel 
stimulator was presented which is able to stimulate different targets with different treatment 
protocols simultaneously (Roth, Levkovitz, Pell, Ankry, & Zangen, 2014). Using such a 
stimulator, a simultaneous triple-site stimulation would be possible where the exact timing of 
pulses between e.g. the temporoparietal cortex and the DLPFC would be an interesting 
parameter to investigate. 
 Finally, an important optimization approach will be the identification of predictors for 
treatment response. The results of study 1 indicate that there might be certain characteristics 
in the brain which define whether a patient will benefit from rTMS treatment. Furthermore, 
the above mentioned study investigating repeated rTMS courses found that patients who 
responded to the first treatment course did not necessarily respond to the second treatment 
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course and the same was true for nonresponders (Lehner et al., 2015). Therefore, there do not 
seem to be hard categories such as “rTMS responders” per se but this preparedness to 
respond to rTMS might change over time – an assumption which is in line with the known 
state-dependent effect of rTMS (Dayan et al., 2013). This also explains why it is difficult to 
find clinical or demographical variables which predict treatment response: Probably, it is not 
those variables which are important but rather the effect they have on brain activity and this 
effect might be different in every tinnitus patient and every point in time. Methods which are 
able to measure the “state” a tinnitus brain is in – such as fMRI or EEG –  might help to 
identify state-dependent predictors for rTMS response even better than e.g. VBM analyses. In 
the course of study 3, longitudinal EEG and fMRI data were collected. Maybe, these data will 
be able to provide some knowledge about which activity patterns predict a response to single- 
or triple-site rTMS treatment. All in all, a more individualized treatment approach which 
adapts rTMS treatment to an individual’s patient needs is a promising albeit distant goal for 
future research. This approach will need to take tinnitus-specific and also tinnitus-unspecific 
morphological and activational brain differences into account. Tailoring rTMS protocols to 
the state of an individual’s brain at a specific point in time with having a specific “target 
state” in mind would therefore be the ultimate goal for rTMS treatment – both in tinnitus 
patients and in other psychiatric and neurological symptoms. A very important step towards 
this goal is to find out, which patients benefit from which protocol and why. 
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